<B8F1C2F72E687770>

Similar documents
ๆญฏkjmh2004v13n1.PDF

Microsoft Word - 9-์‹ ์˜ํ•™.doc


Microsoft Word - 11-์šฐ์˜๋Œ€.doc

ฮฑ ฮฑ ฮฑ ฮฑ ฮฑ

๊ณ ํ’ˆ๊ฒฉ cdna ํ•ฉ์„ฑ์„์œ„ํ•œ RT Kit M-MLV RTase ์˜ RNase H domain ์— mutation ์‹œํ‚ค๋ฏ€๋กœ RNase H activity ๋ฅผ๋‚ฎ์ถ”๊ณ , mrna ์˜ degradation ์„๋ฐฉ์ง€ํ•˜์—ฌ cdna ํ•ฉ์„ฑํšจ์œจ์„๋†’์ž„ d... qpcr RT Kit ์˜ cdn

์ฃผ๊ฐ„๊ฑด๊ฐ•๊ณผ์งˆ๋ณ‘ ์ œ 11 ๊ถŒ์ œ 26 ํ˜ธ ์—ฐ๊ตฌ๋‹จ์‹ , Brief report 2017 ๋…„์•„๋‚˜ํ”Œ๋ผ์ฆˆ๋งˆ์ฆ์‹คํ—˜์‹ค์ง„๋‹จ๊ฒ€์‚ฌ๊ฒฐ๊ณผ ์งˆ๋ณ‘๊ด€๋ฆฌ๋ณธ๋ถ€๊ฐ์—ผ๋ณ‘๋ถ„์„์„ผํ„ฐ์„ธ๊ท ๋ถ„์„๊ณผ์ด๊ฒฝ์•„, ํ™ฉ์„ ๋„, ๊ฐ•๋ณ‘ํ•™, ๊น€์žฌ์˜ฅ * * ๊ต์‹ ์ €์ž : / Laborat

๋ฏธ์ƒ๋ฌผ๋ถ„๋ฅ˜๋Š”ํ˜•ํƒœ์ ํŠน์ง•, ์ƒ๋ฆฌ ์ƒํ™”ํ•™์ ์„ฑ์งˆ๊ณผ์ƒํƒœ, ํ™”ํ•™๋ถ„๋ฅ˜ํ•™์ ์„ฑ์งˆ๊ณผ์ƒํƒœ๋“ฑ์„์ด์šฉํ•˜์—ฌ๊ตฌ๋ถ„ํ•˜๋Š”๊ฒƒ์ด์ผ๋ฐ˜์ ์ด์ง€๋งŒ, ์ด์™€๊ฐ™์€๋ฐฉ๋ฒ•์„์ด์šฉํ•˜๋ฉด๋งŽ์€์‹œ๊ฐ„์„ํ•„์š”๋กœํ•œ๋‹ค. ๋˜ํ•œ๋ถ„๋ฅ˜๊ฐ€ํž˜๋“ ๊ฒฝ์šฐ๋‚˜, ์ •ํ™•ํ•˜์ง€๋ชปํ•œ๊ฒฐ๊ณผ๋ฅผ์–ป๋Š”๊ฒฝ์šฐ๋„์žˆ๋‹ค. ์ตœ๊ทผ๋ฏธ์ƒ๋ฌผ๋ถ„๋ฅ˜์—๋„๋ถ„์ž์ƒ๋ฌผํ•™์ ์ธ๋ฐฉ๋ฒ•์„์ด์šฉํ•˜์—ฌ, ๋ฏธ์ƒ๋ฌผ์ด๊ฐ€์ง€๊ณ ์žˆ๋Š” DNA๋ฅผ

cdna์˜์‹ ์žฅ๋ฐ˜์‘์ด์ €ํ•ด๋œ๋‹ค. ์ด์™€๊ฐ™์ด AMV ์œ ๋ž˜ RTase ์™€ MoMLV ์œ ๋ž˜ RTase ๋Š”๋ชจ๋‘์ผ์žฅ์ผ๋‹จ์„๊ฐ€์ง€๋‚˜ํ•„์ž๋Š” MoMLV ์œ ๋ž˜ RTase ๋ฅผ์„ ํ˜ธํ•œ๋‹ค. ๋˜๋‘ํšจ์†Œ๋Š”์ตœ์  ph, ์ตœ์ ์—ผ๋†๋„๋“ฑ์—์„œ๋„์ฐจ์ด๊ฐ€์žˆ์œผ๋ฏ€๋กœ์ฃผ์˜ํ•ด์•ผํ•œ๋‹ค. ์ตœ๊ทผ Myers ๋“ฑ์€ RTase ํ™œ์„ฑ๊ณผ PCR

Supplementary Infection & Chemotherapy ์ค‘๋™ํ˜ธํก๊ธฐ์ฆํ›„๊ตฐ์ฝ”๋กœ๋‚˜๋ฐ”์ด๋Ÿฌ์Šค๊ฒ€์‚ฌ์‹ค์ง„๋‹จ์ง€์นจ ๋Œ€ํ•œ์ง„๋‹จ๊ฒ€์‚ฌ์˜ํ•™ํšŒ ๋ฉ”๋ฅด์Šค์—๋Œ€ํ•œ๊ธฐ๋ณธ์„ค๋ช… 1. ํ•œ๊ธ€๋ช… 2. ์˜๋ฌธ๋ช… Detection of Middle East Respiratory Syndrome Coronav

Cloning


- 1 -

๋ชฉ์ฐจ โ… . ๊ฐœ์š” 1 โ…ก. ์šฉ์–ด์˜์ •์˜ 4 โ…ข. ๊ด€๋ จ๊ทœ์ • 13 โ…ฃ. ์‹ ์ฒญ์„œ๊ธฐ์žฌํ•ญ๋ชฉ๋ฐ๊ธฐ์ˆ ๋ฌธ์„œ์ œ์ถœ์ž๋ฃŒ 14 โ…ค. ์ œ์กฐ ์ˆ˜์ž…ํ—ˆ๊ฐ€์‹ ์ฒญ์„œ๊ธฐ์žฌํ•ญ๋ชฉ 15

<B8F1C2F72E687770>

๊ฒจ ์šธ ์ฒ  ์žฅ ์—ผ [๊ทธ๋ฆผ1] ์งˆ๋ณ‘๊ด€๋ฆฌ๋ณธ๋ถ€ ๊ธ‰์„ฑ๊ฐ์—ผ์ฆ ๋ณ‘์›์ฒด ํ‘œ๋ณธ๊ฐ์‹œ ๊ธ‰์„ฑ ์œ„์žฅ์—ผ์€ ์„ธ๊ณ„์ ์œผ๋กœ ์œ ๋ณ‘์œจ๊ณผ ์‚ฌ๋ง๋ฅ ์ด ๋†’์€ ๊ฐ์—ผ์„ฑ ์งˆํ™˜์œผ๋กœ, ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ์ฃผ๋œ ์›์ธ ๋ณ‘์›์ฒด์ด๋‹ค. ๊ธ‰์„ฑ ์œ„์žฅ์—ผ์˜ ์›์ธ ๋ฐ”์ด๋Ÿฌ์Šค ์ค‘์—๋Š” ๋กœํƒ€๋ฐ”์ด๋Ÿฌ์Šค(rotavirus), ๋…ธ๋กœ๋ฐ”์ด๋Ÿฌ์Šค(norovirus)

์—ฐ๊ตฌ๋ณด๊ณ ์„œํ™”ํ•™๋ฌผ์งˆ๋…ธ์ถœ์—์˜ํ•œ์œ ์ „์ž๋Œ์—ฐ๋ณ€์ด ( ๋ฐœ์•” ) ์˜์กฐ๊ธฐํ™•์ธ (II) - ์‹คํ—˜๋™๋ฌผ์„์ด์šฉํ•œ๊ณ ๊ฐ๋„๋ฐœ์•”์„ฑํ™•์ธ๊ธฐ๋ฒ•์˜๊ฒ€์ฆ - ์ž„๊ฒฝํƒ ๊น€์ˆ˜์ง„

๋ชฉ ์ฐจ โ… . ๊ฐ์—ผ๋ณ‘ํ˜„ํ™ฉ๊ณผ๊ธฐ๋ณธ์ „๋žต 1 1. ๊ธฐ๋ณธ๊ณ„ํš์ˆ˜๋ฆฝ๋ฐฐ๊ฒฝ 2 2. ๊ฐ์—ผ๋ณ‘๋ฐœ์ƒํ˜„ํ™ฉ 3 3. ์ •์ฑ…ํ™˜๊ฒฝ๋ฐ๋ฌธ์ œ์  4 4. ์ •์ฑ…์ถ”์ง„๋ฐฉํ–ฅ 6 5. ๋น„์ „๊ณผ๋ชฉํ‘œ, ์ฃผ์š”๊ณผ์ œ ์„ฑ๊ณผ์ง€ํ‘œ 15 โ…ก. ๊ฐ์—ผ๋ณ‘๋ณ„๋งž์ถคํ˜•๋Œ€์‘ ์ˆ˜์ธ์„ฑ ์‹ํ’ˆ๋งค๊ฐœ๋ฐ์ ‘์ด‰์ „ํŒŒ๊ฐ์—ผ๋ณ‘ ์˜ˆ๋ฐฉ์ ‘์ข…๋Œ€์ƒ

Product Description Apoptosis ํ˜น์€ necrosis๋“ฑ์—์˜ํ•˜์—ฌ์ฃฝ๊ฑฐ๋‚˜์†์ƒ๋œ์„ธํฌ์—์„œ๋ฐฉ์ถœ๋˜๋Š” Lactate dehydrogenase(ldh) ์˜์–‘์„๊ณ ๊ฐ๋„๋กœ์ธก์ •ํ•จ์œผ๋กœ์จ cytotoxicity/cytolysis๋ฅผ๊ฐ„๋‹จํ•˜๊ฒŒ์ธก์ •ํ• ์ˆ˜์žˆ๋Š” kit ์ž…๋‹ˆ๋‹ค. Cytot

2016 ํ•™๋…„๋„์•ฝํ•™๋Œ€ํ•™๋ฉด์ ‘๋ฌธ์ œํ•ด์„ค ๋ฌธ์ œ 2 ์•„๋ž˜์˜์งˆ๋ฌธ์— 3-4๋ถ„์ด๋‚ด๋กœ๋‹ตํ•˜์‹œ์˜ค. ํ‘œํ”ผ์„ฑ์žฅ์ธ์ž์ˆ˜์šฉ์ฒด (epidermal growth factor receptor, EGFR) ๋Š”์ˆ˜์šฉ์ฒดํ‹ฐ๋กœ์‹ ์ธ์‚ฐํ™”ํšจ์†Œ๊ตฐ (receptor tyrosine kinases, RTKs) ์˜์ผ์ข…์œผ๋กœ์„œ์„ธ

PCR DNA Polymerase ์„ ํƒ๊ฐ€์ด๋“œ ์ผ๋ฐ˜์ ์ธ PCR ์‹คํ—˜ Blend Taq / Blend Taq -Plus- Repairing ์ผ๋ฐ˜ DNA polymerase์™€ proofreading ๊ธฐ๋Šฅ์˜ํšจ์†Œ๊ฐ€์„ž์ธ์ œํ’ˆ Taq polymerase ๋ณด๋‹ค 3~4 ๋ฐฐ๋‚ฎ์€ error

:? 5. 2 : 7. 3 : : 1. 1 : : < 1 : - > 14. < 2 : - > < 1 : - > 22. < 2 : - >

์Šฌ๋ผ์ด๋“œ 1

Microsoft Word - Genolution RNAi Manual.doc

<303720C0C7C7D0B0ADC1C220C0E5C0BABCB D E687770>


2013์ง€๋ฐœ-๊ฐ€์„๋‚ด์ง€1004-4



์Šฌ๋ผ์ด๋“œ 1

Automated high multiplex qPCR platform for simultaneous detection and quantification of multiple nucleic acid targets

์ œ 6 ์žฅ ํ˜ˆ์ฒญํ•™์  ๋ฐ˜์‘


- 2 -

๋ชฉ์ฐจ 1. ์„œ๋ก  ์ค„๊ธฐ์„ธํฌ์˜๊ฐ„์„ธํฌ๋ถ„ํ™”๋Šฅํ‰๊ฐ€์‹œ๊ณ ๋ ค์‚ฌํ•ญ ๊ฐ„์„ธํฌ๋ถ„ํ™”๋Šฅํ‰๊ฐ€์‹œํ—˜๋ฒ• ๋ถ„


<5B D31322D31325DB0EDBAB4BFF8BCBA B9D9C0CCB7AFBDBA D BFA120B4EBC7D120C0CFB9DDBBE7C7D720C1B6BBE72E687770>

์˜ˆ๋ฐฉ์ ‘์ข…๊ด€๋ฆฌ๊ณผ

src.xls

๊ตญ๊ฐ€๊ฒฐํ•ต๊ด€๋ฆฌ์‚ฌ์—…


ํ•™์ˆ ์—ฐ๊ตฌ์šฉ์—ญ์‚ฌ์—…์ตœ์ข…๊ฒฐ๊ณผ๋ณด๊ณ ์„œ ๋‡Œ์ฒ™์ˆ˜์•ก๋‚ดํ”„๋ฆฌ์˜จ๊ฒ€์ถœ์ง„๋‹จ๋ฒ•๊ฐœ๋ฐœ์—ฐ๊ตฌ Development of PrPsc(rogue prion) diagnosis in CSF(Cerebrospinal fluid) ์ฃผ๊ด€์—ฐ๊ตฌ๊ธฐ๊ด€ : ( ์ฃผ ) ํ”ผํ”Œ๋ฐ”์ด์˜ค ์งˆ๋ณ‘๊ด€๋ฆฌ๋ณธ๋ถ€

โ… . ์ธํ”Œ๋ฃจ์—”์ž์˜์‚ฌํ™˜์ž๋ฐœ์ƒํ˜„ํ™ฉ 1. ์ฃผ๊ฐ„ํ‘œ๋ณธ๊ฐ์‹œ๊ฒฐ๊ณผ 2012 ๋…„๋„์ œ 16 ์ฃผ์ธํ”Œ๋ฃจ์—”์ž์˜์‚ฌํ™˜์ž๋ถ„์œจ ์€์™ธ๋ž˜ํ™˜์ž 1,000 ๋ช…๋‹น 8.7 ๋ช…์œผ๋กœ์ง€๋‚œ์ฃผ (13.8) ๋ณด๋‹ค๊ฐ์†Œํ•˜์˜€์œผ๋ฉฐ A/H1N1pdm09 ์ธํ”Œ๋ฃจ์—”์ž๋Œ€์œ ํ–‰๊ธฐ๋ฅผ์ œ์™ธํ•œ์ง€๋‚œ 3 ๋…„๊ฐ™์€์ฃผํ‰๊ท ์ธํ”Œ๋ฃจ์—”์ž์˜์‚ฌํ™˜์ž๋ถ„์œจ (4.6/1


Microsoft PowerPoint - Chapter 3-2

7๊ถŒ22ํ˜ธ-์›น.indd

<B8F1C2F72E687770>

1-ํ‘œ์ง€ ๋ฐ ๋ชฉ์ฐจ & 1-์„œ๋ก  (์ตœ์ข…๋ณด๊ณ ์„œ์•ˆ).hwp

Surpass the limit of Polymerase Chain Reaction (PCR) PCR Enzyme Guide High Fidelity PCR ํšจ์†Œ ๋ฒ”์šฉ์ ์ธ PCR ํšจ์†Œ ํŠน์ˆ˜๋ชฉ์ ์„์œ„ํ•œ PCR ํšจ์†Œ - Epigenetics - Multiplex PCR -


Journal of Life Science 2011, Vol. 21. No ฮผ ฮผ

<ํ‘œ 1-2-1> ์‹œ๊ตฐ๋ณ„ ์„ฑ๋ณ„ ์™ธ๊ตญ์ธ ์ฃผ๋ฏผ๋“ฑ๋ก์ธ๊ตฌ ( ) (๋‹จ์œ„ : ๋ช…, %) ๊ตฌ๋ถ„ 2009๋…„ 2010๋…„ ์™ธ๊ตญ์ธ(๊ณ„) ์™ธ๊ตญ์ธ(์—ฌ) ์™ธ๊ตญ์ธ(๋‚จ) ์„ฑ๋น„ ์™ธ๊ตญ์ธ(๊ณ„) ์™ธ๊ตญ์ธ(์—ฌ) ์™ธ๊ตญ์ธ(๋‚จ) ์„ฑ๋น„ ์ „๊ตญ 870, , , ,

Jkbcs016(92-97).hwp

(48-53)Kjbt006.hwp


Microsoft PowerPoint - 9.์œค๋‚˜๋ผ

PowerPoint ํ”„๋ ˆ์  ํ…Œ์ด์…˜


๊ธฐ๊ตฌ๋ช… ph meter volumetric flask Erlenmeyer flask mass cylinder ๋ทฐ๋ ›๋น„์ด์ปค pipet ์ €์šธ์Šคํƒ ๋“œ & ํด๋žจํ”„ isotonicity ์ธก์ •๊ธฐ ํ•„์š”๋Ÿ‰ 500ml์งœ๋ฆฌ 1๊ฐœ, 50ml์งœ๋ฆฌ 5๊ฐœ, 100ml์งœ๋ฆฌ 1๊ฐœ, 250ml์งœ๋ฆฌ 6๊ฐœ

์Šฌ๋ผ์ด๋“œ 1

3์›” ์˜จ๋ผ์ธ ๊ต์œก

01.๋‚ด์ง€์™„์™„

Spring SALE ๊ฐœ๋‚˜๋ฆฌ ๊ฝƒ์ด ํ”ผ์—ˆ์Šต๋‹ˆ๋‹ค! ๋‹น์‹ ์˜ ์–ผ๊ตด์—๋„ ์›ƒ์Œ ๊ฝƒ์ด ํ”ผ์—ˆ์Šต๋‹ˆ๋‹ค! Seakem LE Agarose (Cat. No ) Oneํ•˜๋ฉด ๋ค์œผ๋กœ ํ•œ ๊ฐœ ๋”! 1+1 ๊ธฐ๊ฐ„ : 2011๋…„ 3์›” 2์ผ ~ 4์›” 15์ผ ~ 30 % Sa le ๊ณ ๊ฐ์ง€์›์„ผํ„ฐ

TOYOBO Reagent ๋งŒ์˜๋…๋ณด์ ์ธ๊ธฐ์ˆ  ReverTra Ace M-MLV RTase ์˜ RNase H domain ์— mutation ์‹œํ‚ค๋ฏ€๋กœ RNase H activity ๋ฅผ๋‚ฎ์ถ”๊ณ ,mRNA ์˜ degradation ์„๋ง‰์•„ cdna ํ•ฉ์„ฑํšจ์œจ์„๋†’์ž„ KOD Polyme

ยฐร‡ยฐ๏ฟฝยฐรบรรบยบยด6-2รˆยฃ

<B8F1C2F72E687770>

์˜ˆ๋ฐฉ์ ‘์ข…

<303220C6AFC1FD20BFC0B8EDB5B D E687770>

ใ† - 1 -

์Šฌ๋ผ์ด๋“œ 1

๋“ค์–ด๊ฐ€๋Š”๋ง ์ธํ”Œ๋ฃจ์—”์ž๋ฐ”์ด๋Ÿฌ์Šค๋Š” Orthomyxoviridae๊ณผ์—์†ํ•˜๋Š”๋ฐ”์ด๋Ÿฌ์Šค๋กœ 8๊ฐœ์˜๋ถ„์ ˆ๋œํ˜•ํƒœ์˜๋‹จ์ผ๊ฐ€๋‹ฅ RNA(single stranded negative RNA) ๋กœ๊ตฌ์„ฑ๋˜์–ด์žˆ์œผ๋ฉฐ์‚ฌ๋žŒ์—๊ฒŒ์ธํ”Œ๋ฃจ์—”์ž๋ฅผ์œ ๋ฐœํ•˜๋Š”๋ณ‘์›์ฒด๋Š” A, B, Cํ˜•์œผ๋กœ๊ตฌ๋ถ„๋œ๋‹ค. ํŠนํžˆ Aํ˜•์ธํ”Œ๋ฃจ์—”์ž๋ฐ”์ด๋Ÿฌ์Šค๋Š”

ITEM 1 PCR Enzyme 20% DNA Polymerase Enzyme Quick Selection Guide for Effective PCR DNA Polymerase General PCR / Colony PCR Long PCR (Max. 23 kb) Hot

- 1 -

EZ-Cloning kit

<B0A1C0CCB5E5B6F3C0CE5F E687770>


(120629)_์„ธํฌ๋ฐฐ์–‘_๋ถˆํ™œํ™”_์ธํ”Œ๋ฃจ์—”์ž_๋ฐฑ์‹ _ํ‰๊ฐ€_๊ฐ€์ด๋“œ๋ผ์ธ.hwp

Jkafm093.hwp

๊ธฐ๊ด€๊ณ ์œ ์—ฐ๊ตฌ์‚ฌ์—…๊ฒฐ๊ณผ๋ณด๊ณ 

๋†๋ฆผ์ถ•์‚ฐ์‹ํ’ˆ๋ถ€์žฅ๊ด€๊ท€ํ•˜ ๋ณธ๋ณด๊ณ ์„œ๋ฅผ ๋ฏธ์ƒ๋ฌผ์„ํ™œ์šฉํ•œ์นœํ™˜๊ฒฝ์ž‘๋ฌผ๋ณดํ˜ธ์ œ๋ฐ๋น„๋ฃŒ์˜์ œํ˜•ํ™”์™€ํ˜„์žฅ์ ์šฉ๋งค๋‰ด ์–ผ๊ฐœ๋ฐœ ( ๊ฐœ๋ฐœ๊ธฐ๊ฐ„ : ~ ) ๊ณผ์ œ์˜์ตœ์ข…๋ณด๊ณ ์„œ๋กœ์ œ์ถœํ•ฉ๋‹ˆ๋‹ค ์ฃผ๊ด€์—ฐ๊ตฌ๊ธฐ๊ด€๋ช… : ๊ณ ๋ ค๋ฐ”์ด์˜ค์ฃผ์‹ํšŒ์‚ฌ ( ๋Œ€ํ‘œ์ž ) ๊น€์˜๊ถŒ (

Jksvs019(8-15).hwp

untitled

ํ˜ˆ์•ก์€ํ–‰ ์ž๋™ํ™”์žฅ๋น„ IH-1000์†Œ๊ฐœ์™€ Autovue Innova์™€์˜ ๊ฒฐ๊ณผ๋น„๊ต

์‹คํ—˜ Set Up Guide ์‹คํ—˜์ฃผ์ œ Real Time PCR ์‹คํ—˜์›๋ฆฌ Quantitative Real-Time PCR (qrt-pcr) ์€ 1992๋…„์—๋„์ž…๋˜์–ด์ƒ๋ช…๊ณตํ•™์—์‘์šฉ๋˜๊ธฐ์‹œ์ž‘ํ•˜์˜€์ด๊ธฐ์ˆ ์€์ž˜์•Œ๋ ค์ ธ์žˆ๋Š” PCR๊ธฐ๋ฒ•์„๊ฐœ๋Ÿ‰ํ•œ๊ฒƒ์ด๋‹ค. PCR์€ํ•ต์‚ฐ์˜ํšจ์†Œ์ฆํญ์„์ด์šฉํ•˜๋ฉฐ, ๊ทนํžˆ์ ์€์–‘

2013_1_14_GM์ž‘๋ฌผ์‹ค์šฉํ™”์‚ฌ์—…๋‹จ_์†Œ์‹์ง€_๋‚ด์ง€_์ธ์‡„_์•™์ฝ”๋ฅด130.indd

2018 ASF Standard Operation Procedure ์•„ํ”„๋ฆฌ์นด๋ผ์ง€์—ด๋ณ‘์ง„๋‹จ๊ฐœ์š” : - African swine fever, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter2.

Selection chart of Bioneer s cdna synthesis products Categories Application Product cdna Synthesis Kits One step RT-PCR Kits One step RT-qPCR Kits RTa

01....b

2007๋ฐฑ์„œ-001-ํŠน์ง‘

00๋ชฉ์ฐจ

(291)๋ณธ๋ฌธ7

ยพร‹ยทยนยธยฃยฑรขรรถร„ยงยผ๏ฟฝ1-รƒร–รยพ

Pierce-Plus-Alpha.pdf

ํŠฆ

PowerPoint ํ”„๋ ˆ์  ํ…Œ์ด์…˜

DNA/RNA Amplification Overview AccuPower PreMix series ๋Š”์„ธ๊ณ„์ ์œผ๋กœ๊ธฐ์ˆ ๋ ฅ์„์ธ์ •๋ฐ›์€ํŠนํ—ˆ๊ธฐ์ˆ ๋กœ๋ณด๋‹ค๊ฒฝ์ œ์ ์ธ๊ฐ€๊ฒฉ๊ณผํŽธ๋ฆฌํ•œ๋ฐฉ๋ฒ•์œผ๋กœ์‹คํ—˜ํ• ์ˆ˜์žˆ๋Š”์ œํ’ˆ์ž…๋‹ˆ๋‹ค. Conventional PCR, Real-Time PCR ์ˆ˜ํ–‰์„์œ„ํ•œ DNA ampli

ยฐร‡ยฐ๏ฟฝยฐรบรรบยบยด5-44รˆยฃรƒร–รยพ

1 01 [ ] [ ] plus 002

Slide 1

< ์„œ์‹ 5> ํƒ๊ตฌ๋ณด๊ณ ์„œํ‘œ์ง€ ์ œ 25 ํšŒ์„œ์šธํ•™์ƒํƒ๊ตฌ๋ฐœํ‘œ๋Œ€ํšŒ๋ณด๊ณ ์„œ ์ถœํ’ˆ๋ฒˆํ˜ธ ์œ ๊ธ€๋ ˆ๋‚˜๋ฅผ์ด์šฉํ•œ์‚ฐ์†Œ๋ฐœ์ƒํ™˜๊ฒฝ์˜ํƒ๊ตฌ ์†Œ์†์ฒญํ•™๊ต๋ช…ํ•™๋…„์„ฑ๋ช… ( ํŒ€๋ช… ) ๊ฐ•์„œ๊ต์œก์ฒญ์„œ์šธ๋ฐฑ์„์ค‘ํ•™๊ต 3 ์ž„์‚ฐํ•ด [ ํŒ€์›์ด๋ฆ„ ]

Transcription:

์ œ 10 ์žฅ ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด ํ”ํžˆ์œ ํ–‰์„ฑ์ถœํ˜ˆ์—ด๋กœ์•Œ๋ ค์ ธ์žˆ๋Š”์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด (hemorrhagic fever with renal syndrome, HFRS) ์€ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค (Hantavirus) ์†์˜๋ฐ”์ด๋Ÿฌ์Šค์—์˜ํ•ด์ „ํŒŒ๋˜๋Š”๊ธ‰์„ฑ์—ด์„ฑ์งˆํ™˜์ด๋‹ค. ํ•œ๊ตญ์ „์Ÿ์ค‘ UN๊ตฐ์—์„œ์•ฝ 3,200๋ช…์ด์ƒ์˜์›์ธ๋ถˆ๋ช…๊ธ‰์„ฑ์ถœํ˜ˆ์—ดํ™˜์ž๊ฐ€๋ฐœ์ƒํ•˜๊ณ ์ˆ˜๋ฐฑ๋ช…์ด์‚ฌ๋งํ•จ์œผ๋กœ์„œ์•Œ๋ ค์ง€๊ธฐ์‹œ์ž‘ํ•˜์˜€๋‹ค. ์ดํ›„๋ฏธ๊ตฐ์˜ํ•™์ž๋ฐ๊ด€๋ จ๋ฏผ๊ฐ„ํ•™์ž๋“ค์—์˜ํ•ด์›์ธ๋ณ‘์›์ฒด์—๋Œ€ํ•œ์—ฐ๊ตฌ๊ฐ€์ง„ํ–‰๋˜์–ด์•ฝ 15๋…„๊ฐ„๋ณ‘์›์ฒด๋ถ„๋ฆฌ๋ฅผ์‹œ๋„ํ•˜์˜€์œผ๋‚˜์„ฑ๊ณตํ•˜์ง€๋ชปํ•˜๋‹ค๊ฐ€, 1976๋…„๋งˆ์นจ๋‚ด์šฐ๋ฆฌ๋‚˜๋ผ์˜์ดํ˜ธ์™•๋ฐ•์‚ฌ์—์˜ํ•ด์„œ์ฒ˜์Œ์œผ๋กœ์›์ธ๋ณ‘์›์ฒด๊ฐ€๋ฐํ˜€์กŒ๋‹ค [9]. ์ฒ˜์Œ๋ฐœ๊ฒฌ๋‹น์‹œ์—๋Š”๋‹จ์ง€ Korea ํ•ญ์› ์œผ๋กœ๋ช…๋ช…ํ•˜์˜€์œผ๋‚˜, ๊ทธํ›„ RNA ๋ฐ”์ด๋Ÿฌ์Šค์ž„์„๋ฐํžˆ๊ณ ํ•œํƒ„๋ฐ”์ด๋Ÿฌ์Šค (Hantaan virus) ๋กœ๋ช…๋ช…ํ•˜์˜€๋‹ค. ์†Œ๋ จ์˜์ถœํ˜ˆ์„ฑ์‹ ์šฐ์‹ ์—ผ, ์Šค์นธ๋””๋‚˜๋น„์•„์ œ๊ตญ์˜์œ ํ–‰์„ฑ์‹ ์—ผ, ์ผ๋ณธ์˜์œ ํ–‰์„ฑ์ถœํ˜ˆ์—ด, ์ค‘๊ตญ์˜์†ก๊ณ ์—ด๋“ฑํ•œ๊ตญํ˜•์ถœํ˜ˆ์—ด๊ณผ์ž„์ƒ์ ์œผ๋กœ์œ ์‚ฌํ•œ์งˆ๋ณ‘๋“ค์˜์›์ธ์ดํ•œํƒ„๋ฐ”์ด๋Ÿฌ์Šคํ˜น์€์ด์™€์œ ์‚ฌํ•œ๋ฐ”์ด๋Ÿฌ์Šค์—์˜ํ•ด๋ฐœ๋ณ‘๋œ๋‹ค๋Š”์‚ฌ์‹ค์ด์ž…์ฆ๋˜์–ด 1982๋…„์„ธ๊ณ„๋ณด๊ฑด๊ธฐ๊ตฌ์—์„œ๋น„์Šทํ•œ์งˆ๋ณ‘์„ํ†ต์นญํ•˜์—ฌ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด๋กœ๋ช…๋ช…ํ•˜๊ฒŒ๋˜์—ˆ๋‹ค [12]. ํ˜„์žฌ WHO์—์„œ๋Š”์œ ๋Ÿฝ๊ณผ์•„์‹œ์•„์ง€์—ญ์—์„œ๋งค๋…„ 6๋งŒ~15๋งŒ๋ช…์ด์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด๋กœ๋ณ‘์›์—์ž…์›ํ•˜๋Š”๊ฒƒ์œผ๋กœ์ถ”์ •ํ•˜๊ณ ์žˆ๋‹ค [8]. ์ด์งˆํ™˜์€๋ฐ”์ด๋Ÿฌ์Šค์—๊ฐ์—ผ๋œ์„ค์น˜๋ฅ˜์˜์†Œ๋ณ€, ๋Œ€๋ณ€, ํƒ€์•ก๋“ฑ์„ํ†ตํ•˜์—ฌ๋ถ„๋น„๋˜๋Š”๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ์‚ฌ๋žŒ์ดํก์ž…ํ•˜๊ฒŒ๋จ์œผ๋กœ์จ๋ฐœ์ƒํ•œ๋‹ค. ์ž ๋ณต๊ธฐ๋Š” 1์ฃผ~3์ฃผ์ด๋ฉฐ๋Œ€์ฒด๋กœ๋ฐœ์—ด๊ธฐ, ์ €ํ˜ˆ์••๊ธฐ, ํ•๋‡จ๊ธฐ, ์ด๋‡จ๊ธฐ, ํšŒ๋ณต๊ธฐ๋“ฑ 5๋‹จ๊ณ„์˜ํŠน์ง•์ ์ธ์–‘์ƒ์„๋ณด์ธ๋‹ค. ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์€๋งค๋…„๊ฐ€์„์ฒ ์—์ฃผ๋กœ๋ฐœ์ƒํ•˜๋Š”์งˆํ™˜์œผ๋กœํ™˜ ์ œ 10 ์žฅ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด 797

์ž์˜๋Œ€๋‹ค์ˆ˜๊ฐ€ 10์›”๋ถ€ํ„ฐ 1์›”๊นŒ์ง€์˜์‹œ๊ธฐ์—๋†์ดŒ์ง€์—ญ์—์„œ๋ฐœ๋ณ‘๋œ๋‹ค. ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์˜ˆ๋ฐฉ์„์œ„ํ•ด์„œ๋Š”์•ผ์™ธํ™œ๋™์‹œ์—๋“ค์ฅ๋ฐฐ์„ค๋ฌผ๊ณผ์˜์ ‘์ด‰์„์ตœ๋Œ€ํ•œํ”ผํ•˜๊ณ ๊ณ ์œ„ํ—˜๊ตฐ์˜๊ฒฝ์šฐ๋ฐฑ์‹ ์ ‘์ข…์„ํ†ตํ•ด์˜ˆ๋ฐฉํ• ์ˆ˜์žˆ๋‹ค. ๋ณ‘์›์ฒด ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์„์ผ์œผํ‚ค๋Š”๋ณ‘์›์ฒด๋Š” Bunyaviridae ๊ณผ์˜ Hantavirus ์†์—ํฌํ•จ๋˜๋Š”๋ฐ”์ด๋Ÿฌ์Šค๋“ค์ด๋ฉฐ, ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์†์—์†ํ•˜๋Š”๋ฐ”์ด๋Ÿฌ์Šค๋“ค์€์›ํ˜•์ธํ•œํƒ„๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ๋น„๋กฏํ•˜์—ฌํ˜„์žฌ 20์—ฌ์ข…์ด๋ณด๊ณ ๋˜์—ˆ๋‹ค. ๊ทธ์ค‘์—์„œ๋Œ€ํ‘œ์ ์ธ๋ฐ”์ด๋Ÿฌ์Šค์ข…, ์ˆ™์ฃผ๋ฐ๋ฐœ์ƒ์ง€์—ญ์€ํ‘œ 1๊ณผ๊ฐ™๋‹ค. ์ด๋“ค๋ฐ”์ด๋Ÿฌ์Šค๋Š”์ผ๋ฐ˜์ ์œผ๋กœ์›์ˆญ์ด์‹ ์žฅ์œ ๋ž˜์„ธํฌ์ฃผ์ธ Vero E6 ์„ธํฌ์ฃผ์—์„œ๊ฐ€์žฅ์ ํ•ฉํ•˜๊ฒŒ์ฆ์‹ํ• ์ˆ˜์žˆ์œผ๋‚˜์ฆ์‹์†๋„๋Š”๋น„๊ต์ ๋Š๋ฆฐํŽธ์œผ๋กœ์ตœ๋Œ€์ฆ์‹๋Ÿ‰์—๋„๋‹ฌํ•˜๊ธฐ๊นŒ์ง€ 5~14์ผ์ด์†Œ์š”๋œ๋‹ค. ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค๋Š”์„ธํฌ๋ณ‘๋ณ€ํšจ๊ณผ๋ฅผ๋‚˜ํƒ€๋‚ด์ง€์•Š๊ฑฐ๋‚˜์•ฝํ•œ์ˆ˜์ค€์œผ๋กœ๋‚˜ํƒ€๋‚ธ๋‹ค. ํ‘œ 1. ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์† ๋ฐ”์ด๋Ÿฌ์Šค์ข…์ˆ™์ฃผ์„ค์น˜๋ฅ˜๋ฐœ์ƒ์ง€์—ญ์›์ธ์งˆ๋ณ‘ Hantaan Dobrava-Belgrade Seoul Puumala Apodemus agrarius Apodemus flavicollis Rattus norvegicus Clethrionomys glareolus ์•„์‹œ์•„, ๊ทน๋™๋Ÿฌ์‹œ์•„๋ฐœ์นธ๋ฐ˜๋„, ์œ ๋Ÿฝ์ „์„ธ๊ณ„์œ ๋Ÿฝ ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด (HFRS) Sin Nombre New York Black Creek Canal Bayou Laaguna Negra Andes Peromyscus maniculatus Peromyscus leucopus Sigmodon hispidus Oryzomys palustris Calomys laucha Oligoryzomys longicaudatus ๋ถ๋ฏธ๋ถ๋ฏธ๋ฏธ๊ตญ๋ฏธ๊ตญ๋‚จ์„œ๋ถ€๋‚จ๋ฏธ๋‚จ๋ฏธ ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šคํ์ฆํ›„๊ตฐ (HPS) Prospect Hill Tula Microtus pennsylvanicus Microtus arvalis ๋ถ๋ฏธ์œ ๋Ÿฝ ๋น„๋ณ‘์›์„ฑ ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค๋Š”ํ˜•ํƒœ์ ์œผ๋กœ์ง๊ฒฝ 100~120 nm์˜๊ตฌํ˜•์ด๋‹ค. ์ค‘์‹ฌ๋ถ€์—๋Š” 3๊ฐœ์˜ RNA ์œ ์ „์ž์™€์ด๋ฅผ๋‘˜๋Ÿฌ์‹ผ๋‹จ๋ฐฑ์œผ๋กœ๊ตฌ์„ฑ๋œ๋ฆฌ๋ณดํ•ต์‚ฐ๋‹จ๋ฐฑ์งˆ (ribonucleoprotein, RNP) ๊ตฌ์กฐ๊ฐ€์žˆ๊ณ , ์ด RNP ๊ตฌ์กฐ๋ฅผ 5 nm์˜์ง€์งˆ์ด์ค‘์ธต๊ณผ๋‹น๋‹จ๋ฐฑ์งˆ์ธ G1, G2๊ฐ€๋‘˜๋Ÿฌ์‹ธ๊ณ ์žˆ๋‹ค. ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์˜์œ ์ „์ž๋Š”๋‹จ์ผ๊ฐ€๋‹ฅ (-) RNA๋กœ large (L), medium (M) ๊ทธ๋ฆฌ๊ณ  798 ๊ฐ์—ผ๋ณ‘์‹คํ—˜์‹ค์ง„๋‹จ์ œ 4 ๋ถ€๋ฐ”์ด๋Ÿฌ์Šค์งˆํ™˜

small (S) ์˜ 3๊ฐœ๋ถ„์ ˆ๋กœ๊ตฌ์„ฑ๋˜์–ด์žˆ๋‹ค. ๊ฐ๊ฐ์€ RNA ์˜์กด RNA ์ค‘ํ•ฉํšจ์†Œ (RNAdependent RNA polymerase, RdRp), ๋‹น๋‹จ๋ฐฑ์งˆ (G1, G2), ๊ทธ๋ฆฌ๊ณ ๋‰ดํด๋ ˆ์˜ค์บก์‹œ๋“œ๋‹จ๋ฐฑ์งˆ์„์•”ํ˜ธํ™”ํ•œ๋‹ค. ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค RNA ์œ ์ „์ž๋Š” 5 ๊ณผ 3 ๋ง๋‹จ์˜๋ณด์กด๋œ์—ผ๊ธฐ์„œ์—ด๋กœ์ธํ•ด์„œ๋ถ€์ฑ„๋ชจ์–‘๊ตฌ์กฐ๋ฅผํ˜•์„ฑํ•˜๋ฉฐ์ด๋Ÿฌํ•œ๊ตฌ์กฐ๋Š”๋ฐ”์ด๋Ÿฌ์Šค์˜์ „์‚ฌ์™€๋ณต์ œ๋ฅผ์กฐ์ ˆํ•˜๋Š”๋ฐ์ค‘์š”ํ•œ์—ญํ• ์„ํ•˜๋Š”๊ฒƒ์œผ๋กœ์•Œ๋ ค์ ธ์žˆ๋‹ค [11]. ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค๋Š”ํด๋กœ๋กœํฌ๋ฆ„, ์—ํ…Œ๋ฅด- ์•Œ์ฝœ, ํŽ˜๋†€, β-propiolactone, sodium hypochloride ๋˜๋Š” ph๊ฐ€ 5.0 ์ดํ•˜์ธ์‚ฐ์„ฑ์šฉ์•ก์†์—์„œ๋ถˆํ™œ์„ฑํ™”๋˜๊ณ  60 ์—์„œ 30๋ถ„๊ฐ„์—ด์ฒ˜๋ฆฌํ•˜๋Š”๊ฒƒ์œผ๋กœ๋„๋ถˆํ™œ์„ฑํ™”์‹œํ‚ฌ์ˆ˜์žˆ๋‹ค. IFA์šฉ์Šฌ๋ผ์ด๋“œ๊ธ€๋ผ์Šค์œ„์—๋„ํฌํ•œ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€์ ‘์ข…๋œ Vero E6 ์„ธํฌ๋‚ด์˜๋ฐ”์ด๋Ÿฌ์Šค๋Š”์•„์„ธํ†ค๊ณ ์ •๊ณผ์ •๋™์•ˆ์™„์ „ํžˆ๋ถˆํ™œ์„ฑํ™”๋œ๋‹ค. ์ž„์ƒ์ฆ์ƒ ํ•œํƒ„๋ฐ์„œ์šธ๋ฐ”์ด๋Ÿฌ์Šค์—์˜ํ•œ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์€๋ณดํ†ต 1~3์ฃผ์˜์ž ๋ณต๊ธฐ๋ฅผ๊ฑฐ์นœํ›„๋ฐœ๋ณ‘ํ•˜๋Š”๋ฐ์ „ํ˜•์ ์ธ์ฆ์„ธ๋Š”๋ฐœ์—ด, ์ถœํ˜ˆ๊ทธ๋ฆฌ๊ณ ์‹ ๋ถ€์ „๋“ฑ์ด๋ฉฐ๋ณ‘์˜์ง„ํ–‰์ •๋„์—๋”ฐ๋ผ 5 ๋‹จ๊ณ„๋กœ๊ตฌ๋ถ„ํ• ์ˆ˜์žˆ์œผ๋ฉฐ ( ํ‘œ 2), ๊ฐ๋‹จ๊ณ„๋ณ„์ฃผ์š”์ฆ์ƒ์€๋‹ค์Œ๊ณผ๊ฐ™๋‹ค [3]. ํ‘œ 2. ํ•œํƒ„๋ฐ”์ด๋Ÿฌ์Šค๊ฐ์—ผ์—์˜ํ•œ๋‹จ๊ณ„๋ณ„์ž„์ƒ๊ฒฝ๊ณผ [10] ๋‹จ๊ณ„๋นˆ๋„ (%) ์ฆ์ƒ๊ฐœ์‹œ์ผ์ผ๋ฐ˜์ ์ธ์ง€์†๊ธฐ๊ฐ„์ง€์†๊ธฐ๊ฐ„๋ฒ”์œ„ ๋ฐœ์—ด๊ธฐ 100 1 3~6 ์ผ 2~10 ์ผ ์ €ํ˜ˆ์••๊ธฐ 37 4~6 1 ์ผ ์ˆ˜์‹œ๊ฐ„ ~3 ์ผ ํ•๋‡จ๊ธฐ 60 6~8 3~5 ์ผ 1~16 ์ผ ์ด๋‡จ๊ธฐ 95 9~14 7~14 ์ผ ์ˆ˜์ผ ~ ์ˆ˜์ฃผ ํšŒ๋ณต๊ธฐ 15~21 4~8 ์ฃผ 3~12 ์ฃผ 1 ๋ฐœ์—ด๊ธฐ ๊ฐ‘์ž๊ธฐ์‹œ์ž‘ํ•˜๋Š”๋ฐœ์—ด, ๊ถŒํƒœ๊ฐ, ์‹์š•๋ถ€์ง„, ์‹ฌํ•œ๋‘ํ†ต๋“ฑ์ด๋‚˜ํƒ€๋‚˜๊ณ ๋ณตํ†ต, ์š”ํ†ต, ์–ผ๊ตด๊ณผ๋ชธํ†ต์˜๋ฐœ์ , ๊ฒฐ๋ง‰์ถฉํ˜ˆ, ์ถœํ˜ˆ๋ฐ˜๋“ฑ์ด์ฐจ์ฐจ๋ฐœ์ƒํ•œ๋‹ค. 2 ์ €ํ˜ˆ์••๊ธฐ์ „์‹ ์ฆ์ƒ์ด์ง€์†๋˜๊ณ , ํ•ด์—ด๊ณผ๋™์‹œ์—ํ˜ˆ์••์ด๋–จ์–ด์ ธ๋ถˆ์•ˆํ•ด๋ณด์ด๋ฉฐ์‹ฌํ•˜๋ฉด์ฐฉ๋ž€, ์„ฌ๋ง, ํ˜ผ์ˆ˜๋“ฑ์‡ผํฌ์ฆ์ƒ์„๋ณด์ด๋ฉฐ์‹ฌํ•œ๋‹จ๋ฐฑ๋‡จ, ๋นˆ๋‡จ๊ฐ€๋‚˜ํƒ€๋‚˜๊ณ , ํ˜ˆ์†ŒํŒ๊ฐ์†Œ, ๋ฐฑํ˜ˆ๊ตฌ ์ œ 10 ์žฅ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด 799

์ฆ๊ฐ€, ํ˜ˆ๋‡จ, ํ† ํ˜ˆ, ์ ํ˜ˆ๊ตฌ์šฉ์  (hematocrit) ์ƒ์Šน๋“ฑ์˜์ถœํ˜ˆํ˜„์ƒ์ด๋‚˜ํƒ€๋‚œ๋‹ค. 3 ํ•๋‡จ๊ธฐํ˜ˆ์••์ด์ •์ƒํ˜น์€๋–จ์–ด์ง€๋ฉฐ์˜ค์‹ฌ, ๊ตฌํ† , ํ•๋‡จ, ์งˆ์†Œํ˜ˆ์ฆ, ์ „ํ•ด์งˆ์ด์ƒ (K ์ฆ๊ฐ€ ) ๋•Œ๋กœ๋Š”๋‡Œ๋ถ€์ข…, ํ์ˆ˜์ข…๋„๋ณผ์ˆ˜์žˆ์œผ๋ฉฐ, ๋ฐ˜์ƒ์ถœํ˜ˆ, ์ž๋ฐ˜, ์œ„์žฅ๊ด€์ถœํ˜ˆ์ดํ˜„์ €ํ•ด์ง€๊ณ ์†Œ๋ณ€์ด๋‚˜์˜ค์ง€์•Š๋Š”๋‹ค. 4 ์ด๋‡จ๊ธฐ์‹ ๊ธฐ๋Šฅ์ดํšŒ๋ณต๋˜๋Š”์‹œ๊ธฐ๋กœ๋‹ค๋‡จ (3~6 l/ ์ผ ) ๊ฐ€๋™๋ฐ˜๋˜๋ฉฐ, ์‹ฌํ•œํƒˆ์ˆ˜, ์‡ผํฌ, ํํ•ฉ๋ณ‘์ฆ์œผ๋กœ์‚ฌ๋งํ• ์ˆ˜์žˆ๋‹ค. 5 ํšŒ๋ณต๊ธฐ๊ฐ€๋”๋‹ค๋‡จ๊ฐ€์ง€์†๋˜๊ฑฐ๋‚˜์•ผ๋‡จ, ๋นˆํ˜ˆ์ฆ์ƒ์ด์žˆ๋‹ค. ์—ญํ•™ ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์†์˜๋ฐ”์ด๋Ÿฌ์Šค๋“ค์€๋Œ€๋ถ€๋ถ„๊ฐ๊ฐ์˜์ข…๋งˆ๋‹ค๊ณ ์œ ํ•œ์•ผ์ƒ์„ค์น˜๋ฅ˜๋ฅผ์ž์—ฐ๊ณ„์˜์ˆ™์ฃผ๋กœ์‚ผ๊ณ ์žˆ๋‹ค. ํ•œํƒ„๋ฐ”์ด๋Ÿฌ์Šค๋Š”๋“ค์ฅ์˜ 72~90% ๋ฅผ์ฐจ์ง€ํ•˜๋Š”๋“ฑ์ค„์ฅ๊ฐ€์ฃผ๋กœ๋งค๊ฐœํ•˜๋ฉฐ, ์„œ์šธ๋ฐ”์ด๋Ÿฌ์Šค์˜๊ฒฝ์šฐ๋Š”๋„์‹œ์˜์‹œ๊ถ์ฅ๊ฐ€๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ์ „ํŒŒํ•œ๋‹ค. ์„ค์น˜๋ฅ˜๋“ค์ดํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์—๊ฐ์—ผ๋˜๋ฉด๋ณ‘์ ์ฆ์ƒ์€๋‚˜ํƒ€๋‚˜์ง€์•Š์ง€๋งŒํƒ€์•ก, ์†Œ๋ณ€, ๋ถ„๋ณ€์„ํ†ตํ•ด๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ์ฒด์™ธ๋กœ๋ถ„๋น„ํ•˜๊ณ ์ด๊ฒƒ์ด๊ฑด์กฐ๋˜์–ด๋จผ์ง€์™€ํ•จ๊ป˜๊ณต์ค‘์—๋– ๋‹ค๋‹ˆ๋‹ค๊ฐ€ํ˜ธํก๊ธฐ๋ฅผํ†ตํ•ด์‚ฌ๋žŒ์—๊ฒŒ๊ฐ์—ผ๋˜๋Š”๊ฒƒ์œผ๋กœ์ถ”์ •๋œ๋‹ค. ํ˜„์žฌ๊นŒ์ง€์‚ฌ๋žŒ๊ฐ„์ „ํŒŒ๊ฐ€๋ณด๊ณ ๋œ์ ์€์—†๋‹ค [8, 11]. ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์€์šฐ๋ฆฌ๋‚˜๋ผ๋ฅผ๋น„๋กฏํ•˜์—ฌ์ค‘๊ตญ, ๋Ÿฌ์‹œ์•„๋“ฑ๋™๋ถ์•„์‹œ์•„์™€์Šค์นธ๋””๋‚˜๋น„์•„๋ฐ˜๋„, ์œ ๋Ÿฝ๋ฐ๋ถ๋‚จ๋ฏธ์ง€์—ญ๋“ฑ์„ธ๊ณ„์ ์ธ๋ถ„ํฌ๋ฅผ๋ณด์ด๋ฉฐ์—ฐ๊ฐ„ํ™˜์ž๋ฐœ์ƒ์ˆ˜๋Š” 6~15๋งŒ๋ช…์œผ๋กœ์ถ”์ •๋œ๋‹ค. ์ด์ค‘์ ˆ๋ฐ˜์ด์ค‘๊ตญ์—์„œ๋ฐœ์ƒํ•˜๋ฉฐ๋Ÿฌ์‹œ์•„์—์„œ๋„๋งค๋…„์ˆ˜๋ฐฑ์—์„œ์ˆ˜์ฒœ๋ช…์ด๋ฐœ์ƒํ•˜๋Š”๊ฒƒ์œผ๋กœ๋ณด๊ณ ๋˜๊ณ ์žˆ๋‹ค [4, 8]. ๊ตญ๋‚ด์—์„œ๋Š” 1951๋…„๋ถ€ํ„ฐ 1954๋…„๊นŒ์ง€์˜๊ธฐ๊ฐ„๋™์•ˆ UN๊ตฐ๋ณ‘์‚ฌ์—์„œ 2,500๋ช…๊ฐ€๊นŒ์šดํ™˜์ž๊ฐ€๋ฐœ์ƒํ•˜์˜€๊ณ , 1955๋…„์ดํ›„ UN๊ตฐ์—์„œ์˜ํ™˜์ž์ˆ˜๋Š”๊ธ‰์†ํžˆ๊ฐ์†Œํ•˜์˜€๋‹ค. ๊ตญ๋‚ดํ™˜์ž๋Š”์งˆ๋ณ‘๊ด€๋ฆฌ๋ณธ๋ถ€์˜์ง‘๊ณ„์—์˜ํ•˜๋ฉด 1970๋…„๋Œ€๋ง๋ถ€ํ„ฐ 1990๋…„๋Œ€์ค‘๋ฐ˜๊นŒ์ง€๋…„๊ฐ„ 100๋ช…์ดํ•˜์˜ํ™˜์ž๊ฐ€๋ณด๊ณ ๋˜์—ˆ์œผ๋‚˜, 1998๋…„๋ถ€ํ„ฐ๊พธ์ค€ํžˆ์ฆ๊ฐ€ํ•˜์—ฌ 2003๋…„์—๋Š”์•ฝ 400๋ช…์˜ํ™˜์ž๋ฐœ์ƒ์ด๋ณด๊ณ ๋˜์—ˆ๋‹ค ( ๊ทธ๋ฆผ 1). 800 ๊ฐ์—ผ๋ณ‘์‹คํ—˜์‹ค์ง„๋‹จ์ œ 4 ๋ถ€๋ฐ”์ด๋Ÿฌ์Šค์งˆํ™˜

450 400 350 patient count 300 250 200 150 100 50 0 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 year 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 ๊ทธ๋ฆผ 1. ์—ฐ๋„๋ณ„๊ตญ๋‚ด์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ดํ™˜์ž๋ฐœ์ƒ๋ณด๊ณ ๊ฑด์ˆ˜ [4] ํ™˜์ž์˜๋Œ€๋‹ค์ˆ˜๊ฐ€ 10์›”๋ถ€ํ„ฐ 12์›”๊นŒ์ง€์˜๋Œ€์œ ํ–‰๊ธฐ์—๋ฐœ์ƒ๋˜๋ฉฐ, ์˜ˆ์ „์—๋Š” 5~7์›”์˜์†Œ์œ ํ–‰๊ธฐ์—๋„์†Œ์ˆ˜์˜ํ™˜์ž๊ฐ€์ฆ๊ฐ€ํ•˜๋Š”๊ฒฝํ–ฅ์ด์žˆ์—ˆ์œผ๋‚˜, ์ตœ๊ทผ 3๋…„๊ฐ„ํ†ต๊ณ„๋ฅผ๋ณด์•˜์„๋•Œ์†Œ์œ ํ–‰๊ธฐ๋Š”์ ์ฐจ์‚ฌ๋ผ์ง€๊ณ ์žˆ๋‹ค ( ๊ทธ๋ฆผ 2). ์ง€์—ญ์ ์œผ๋กœ๋Š”ํ™˜์ž์˜๋Œ€๋‹ค์ˆ˜๊ฐ€๋†์ดŒ์ง€์—ญ์—์„œ๋ฐœ์ƒํ•˜๋ฉฐ์ธ๊ตฌ 10๋งŒ๋ช…๋‹น 6๋ช…์ด์ƒ์ด๋ณด๊ณ ๋œ์ง€์—ญ์€๊ฒฝ๊ธฐ๋„์—ฌ์ฃผ, ์ด์ฒœ, ๊ฐ•์›๋„์›์ฃผ, ์ฒ ์›, ์ถฉ์ฒญ๋‚จ๋„๋‹น์ง„, ์„œ์‚ฐ, ์ „๋ผ๋ถ๋„๋‚จ์›, ์ „๋ผ๋‚จ๋„๊ตฌ๋ก€์ง€์—ญ๋“ฑ์ด๋ฉฐ์ƒ๋Œ€์ ์œผ๋กœ๊ฒฝ์ƒ๋‚จ๋„์ง€์—ญ์€๋ฐœ๋ณ‘๋ฅ ์ด๋‚ฎ๋‹ค [4]. 140 120 100 2001 ๋…„ 2002 ๋…„ 2003 ๋…„ 80 60 40 20 0 1 ์›” 2 ์›” 3 ์›” 4 ์›” 5 ์›” 6 ์›” 7 ์›” 8 ์›” 9 ์›” 10 ์›” 11 ์›” 12 ์›” ๊ทธ๋ฆผ 2. ์ตœ๊ทผ 3 ๋…„๊ฐ„๊ตญ๋‚ด์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์›”๋ณ„๋ฐœ์ƒํ˜„ํ™ฉ [4] ์ œ 10 ์žฅ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด 801

์˜ˆ๋ฐฉ๋ฐ๊ด€๋ฆฌ ์‚ฌ๋žŒ๊ฐ„์˜์ „ํŒŒ๋Š”์—†์œผ๋ฏ€๋กœํ™˜์ž๋Š”๊ฒฉ๋ฆฌ์‹œํ‚ฌํ•„์š”๊ฐ€์—†๋‹ค. ํ˜„์žฌ๊นŒ์ง€์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์—๋Œ€ํ•ด๋ฆฌ๋ฐ”๋น„๋ฆฐ (ribavirin) ์„์ œ์™ธํ•˜๊ณ ํšจ๊ณผ์ ์ธ์น˜๋ฃŒ์ œ๊ฐ€์—†๊ธฐ๋•Œ๋ฌธ์—๋ฐœ๋ณ‘ํ•˜๊ฒŒ๋˜๋ฉด์กฐ๊ธฐ์—์ง„๋‹จํ•˜์—ฌ๋ณ‘์˜๊ฒฝ๊ณผ์—๋”ฐ๋ผ๋Œ€์ฆ์š”๋ฒ•์„์‹ค์‹œํ•˜๋Š”๊ฒƒ๊ณผ๋‹ค๋ฐœ์ง€์—ญ์—์ ‘๊ทผํ•˜์ง€์•Š๋Š”๊ฒƒ์ด์ตœ์„ ์˜์˜ˆ๋ฐฉ๋ฒ•์ด๋ฉฐ, ๊ณ ์œ„ํ—˜์ง€์—ญ์—๊ฑฐ์ฃผํ•˜๊ฑฐ๋‚˜์•ผ์™ธํ™œ๋™์ด๋งŽ์€์‚ฌ๋žŒ์˜๊ฒฝ์šฐ์˜ˆ๋ฐฉ๋ฐฑ์‹ ์„์ ‘์ข…ํ•˜์—ฌ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์—๋Œ€ํ•œ๋ฐœ๋ณ‘๋ฅ ์„๊ฐ์†Œ์‹œํ‚ฌ์ˆ˜์žˆ๋‹ค. ํ˜„์žฌ๊ตญ๋‚ด์—์„œ๋Š”๋งˆ์šฐ์Šค๋‡Œ์—์ ‘์ข…ํ•˜์—ฌ์–ป์€๋ฐ”์ด๋Ÿฌ์Šค๋ฅผํฌ๋ฅด๋ง๋ฆฐ์œผ๋กœ๋ถˆํ™œํ™”ํ•œ๋ฐฑ์‹ ์„์‚ฌ์šฉํ•˜๊ณ ์žˆ์œผ๋ฉฐ, ์ ‘์ข…๋ฐฉ๋ฒ•์€๋ฐฑ์‹  0.5 ml์„ํ•œ๋‹ฌ๊ฐ„๊ฒฉ์œผ๋กœ 2ํšŒ, ํ”ผํ•˜๋˜๋Š”๊ทผ์œก์ฃผ์‚ฌํ•˜๊ณ  12๊ฐœ์›”๋’ค์— 1ํšŒ์ ‘์ข…ํ•˜๋Š”๊ฒƒ์„๊ธฐ์ดˆ๋กœํ•œ๋‹ค [6, 7]. ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์˜์˜ˆ๋ฐฉ์—๋Œ€ํ•œ๊ด€๋ฆฌ๋ฒ•์€๋‹ค์Œ๊ณผ๊ฐ™๋‹ค [3]. 1 ์œ ํ–‰์ง€์—ญ์˜์‚ฐ์ด๋‚˜ํ’€๋ฐญ์—๊ฐ€๋Š”๊ฒƒ์„ํ”ผํ• ๊ฒƒ. ํŠนํžˆ, ๋Šฆ๊ฐ€์„ (10 11์›”) ๊ณผ๋Šฆ๋ด„ (5 6์›” ) ๊ฑด์กฐ๊ธฐ์—๋Š”์ ˆ๋Œ€์ž”๋””์œ„์—๋ˆ•์ง€๋ง๊ฒƒ. 2 ๋“ค์ฅ์˜๋ฐฐ์„ค๋ฌผ์—์ ‘์ด‰์„ํ”ผํ• ๊ฒƒ. 3 ์•ผ์™ธํ™œ๋™ํ›„๊ท€๊ฐ€์‹œ์—๋Š”์˜ท์—๋ฌป์€๋จผ์ง€๋ฅผํ„ธ๊ณ ๋ชฉ์š•์„ํ• ๊ฒƒ. 4 ๊ฐ€๋Šฅํ•œํ•œํ”ผ๋ถ€์˜๋…ธ์ถœ์„์ ๊ฒŒํ• ๊ฒƒ. 5 ๊ฐ์—ผ์œ„ํ—˜์ด๋†’์€์‚ฌ๋žŒ ( ๊ตฐ์ธ, ๋†๋ถ€๋“ฑ ) ์€์ ๊ธฐ์—์˜ˆ๋ฐฉ์ ‘์ข…์„๋ฐ›์„๊ฒƒ. 6 ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์˜์‹ฌ์‹œ์กฐ๊ธฐ์—์ง„๋‹จ๋ฐ์น˜๋ฃŒ๋ฅผ๋ฐ›์„๊ฒƒ. ์‹คํ—˜์‹ค์ง„๋‹จ ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์—๋Œ€ํ•œ์ง„๋‹จ๋ฐฉ๋ฒ•์€๊ฒ€์ฒด์—์„œ๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ์ง์ ‘๋ถ„๋ฆฌํ•˜๋Š”๋ฐฉ๋ฒ•, ํŠน์ดํ•ญ์ฒด๋ฅผ๊ฒ€์ถœํ•˜๋Š”ํ˜ˆ์ฒญํ•™์ ๋ฐฉ๋ฒ•๋˜๋Š”์œ ์ „์ž๋ฅผ๊ฒ€์ถœํ•˜๋Š”๋ฐฉ๋ฒ•์œผ๋กœ๊ตฌ๋ถ„ํ• ์ˆ˜์žˆ์œผ๋ฉฐ์ด๋ฅผ์œ„ํ•ด๋™๋ฌผ์„ธํฌ๋ฐฐ์–‘, ๊ฐ„์ ‘๋ฉด์—ญํ˜•๊ด‘ํ•ญ์ฒด๋ฒ• (IFA), IgM ํฌ์ฐฉํšจ์†Œ๋ฉด์—ญ์ธก์ •๋ฒ• (IgM capture ELISA), RT-PCR ๋ฒ•๋“ฑ์ด์ด์šฉ๋ ์ˆ˜์žˆ๋‹ค [2]. 1. ๊ฒ€์ฒด ๋ฐ”์ด๋Ÿฌ์Šค๋ถ„๋ฆฌ์šฉ๊ฒ€์ฒด๋ฐ RT-PCR ์šฉ๊ฒ€์ฒด๋Š”๊ธ‰์„ฑ๊ธฐํ™˜์žํ˜ˆ์ฒญ๋ฐ์‚ฌ๋ง์ž์—์„œ์˜๋ณ‘ 802 ๊ฐ์—ผ๋ณ‘์‹คํ—˜์‹ค์ง„๋‹จ์ œ 4 ๋ถ€๋ฐ”์ด๋Ÿฌ์Šค์งˆํ™˜

๋ณ€์กฐ์ง์„์‚ฌ์šฉํ•œ๋‹ค. ๊ฐ์—ผ์ดˆ๊ธฐ์˜ํ˜ˆ์•ก์„๋ฐ”์ด๋Ÿฌ์Šค๋ถ„๋ฆฌ๋ฅผ์œ„ํ•ด์„œ๋Š”ํ—คํŒŒ๋ฆฐ์ด์ฒ˜๋ฆฌ๋œ์‹œํ—˜๊ด€์—์ฑ„ํ˜ˆํ•˜๊ณ , ์œ ์ „์ž๊ฒ€์‚ฌ๋ฅผ์œ„ํ•ด์„œ๋Š” EDTA๋ฅผ์ฒ˜๋ฆฌํ•œ์‹œํ—˜๊ด€์—์ฑ„ํ˜ˆํ•˜์—ฌ๋ƒ‰์žฅ๋˜๋Š”๋“œ๋ผ์ด์•„์ด์Šค๋ฅผ๋‹ด์€๋ฐ•์Šค์—๋„ฃ์–ด์ˆ˜์†กํ•œ๋‹ค. ํ•ญ์ฒด์ธก์ •์šฉํ˜ˆ์ฒญ์€๊ธ‰์„ฑ๊ธฐ ( ๋ฐœ๋ณ‘ํ›„ 5์ผ์ด๋‚ด ), ํšŒ๋ณต๊ธฐ ( ๋ฐœ๋ณ‘ํ›„ 14์ผ์ด์ƒ ) ์˜ํ˜ˆ์•ก์„์ฑ„์ทจํ•˜์—ฌ์‚ฌ์šฉํ•œ๋‹ค. ๊ฒ€์ฒด๋Š”์—ฌ๋Ÿฌ์ข…๋ฅ˜์˜์‹œํ—˜์—๋™์‹œ์—์‚ฌ์šฉํ• ์ˆ˜๋„์žˆ์œผ๋ฏ€๋กœ๋™๊ฒฐ๋ณด์กดํ•˜๊ธฐ์ „์—ฌ๋Ÿฌ๊ฐœ์˜์‹œํ—˜๊ด€์œผ๋กœ๋‚˜๋ˆ„์–ด์ €์žฅํ•ด๋†“๋Š”๊ฒƒ์ด๋ฐ”๋žŒ์งํ•˜๋‹ค. ๊ฒ€์ฒด๋ฅผ๋ฐ˜๋ณตํ•ด์„œ๋ƒ‰๋™, ํ•ด๋™ํ•˜๋Š”๊ฒƒ์€์ข‹์ง€์•Š๋‹ค. 2. ๊ฒ€์‚ฌ๋ฐฉ๋ฒ• 1) ์„ธํฌ๋ฐฐ์–‘์—์˜ํ•œ๋ฐ”์ด๋Ÿฌ์Šค๋ถ„๋ฆฌ ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ์ฆ์‹์‹œํ‚ฌ์ˆ˜์žˆ๋Š”์„ธํฌ๋Š”์ธ๊ฐ„ํ์•”์„ธํฌ์ฃผ (A-549), ์ดˆ๋Œ€ํ–„์Šคํ„ฐ์‹ ์žฅ์„ธํฌ (primary hamster kidney cells), ์ดˆ๋Œ€ํฐ์ฅํ์„ธํฌ (primary rat lung cells) ๋“ฑ์ด์žˆ์œผ๋‚˜์ผ๋ฐ˜์ ์œผ๋กœ์›์ˆญ์ด์‹ ์žฅ์œ ๋ž˜์„ธํฌ์ธ Vero E6 ์„ธํฌ์ฃผ๋ฅผ๋ฐ”์ด๋Ÿฌ์Šค์ฆ์‹ ๋ถ„๋ฆฌ์šฉ์œผ๋กœ๊ฐ€์žฅ๋งŽ์ด์ด์šฉํ•œ๋‹ค. 1 25 cm2์กฐ์ง๋ฐฐ์–‘ํ”Œ๋ผ์Šคํฌ๋˜๋Š” 6 ์›ฐํ”Œ๋ ˆ์ดํŠธ์—์„ธํฌ๋ฅผ 70~80% ์„ฑ์žฅํ• ๋•Œ๊นŒ์ง€๋‹จ์ธต๋ฐฐ์–‘ํ•œ๋‹ค. 2 ๋ฐฐ์–‘์•ก์„์ œ๊ฑฐํ•˜๊ณ  PBS๋กœ 1ํšŒ์„ธ์ฒ™, ๊ฒ€์ฒด ( ์กฐ์ง๋ถ„์‡„์ƒ์ธต์•ก, ํ˜ˆ์ฒญ๋˜๋Š”์ „ํ˜ˆ ) ๋ฅผ 25 cm2ํ”Œ๋ผ์Šคํฌํ•œ๊ฐœ๋‹น 0.5~1 ml๋˜๋Š” 6 ์›ฐํ”Œ๋ ˆ์ดํŠธ์˜ํ•œ์›ฐ๋‹น 0.2~0.4 ml์ฒจ๊ฐ€ํ•˜์—ฌ 36 ์—์„œ 1~1.5 ์‹œ๊ฐ„ํก์ฐฉํ•œ๋‹ค ( ๊ต๋ฐ˜๊ธฐ๋ฅผ์ด์šฉํ•˜๊ฑฐ๋‚˜ 20๋ถ„์—ํ•œ๋ฒˆ์”ฉ๊บผ๋‚ดํ”๋“ค์–ด์„œ์„ธํฌ์ฃผ๊ฐ€๋งˆ๋ฅด์ง€์•Š๋„๋กํ•œ๋‹ค ). 3 PBS๋กœ 1ํšŒ์„ธ์ฒ™ํ•˜๊ณ ์ฆ์‹๋ฐฐ์–‘์•ก์„์ฒจ๊ฐ€ํ•œํ›„ 37, 5% CO 2 ๋ฐฐ์–‘๊ธฐ์—์„œ 12~14์ผ๊ฐ„๋ฐฐ์–‘ํ•œ๋‹ค. ๊ทธ๋‹ค์Œ๊ณ„๋Œ€๋ถ€ํ„ฐ๋Š”ํ•œํƒ„๊ณผ์„œ์šธ๋ฐ”์ด๋Ÿฌ์Šค๋Š” 5~7์ผ, ํ‘ธ๋ง๋ผ๋ฐ”์ด๋Ÿฌ์Šค๋Š” 10~14์ผ๋ฐฐ์–‘ํ•œ๋‹ค. 4 ํŠธ๋ฆฝ์‹ ์œผ๋กœ๋‹จ์ธต์„ธํฌ๋ฅผ๋ถ„๋ฆฌํ•˜์—ฌ์ผ๋ถ€ ( ์•ฝ 1 ml ) ๋Š” IFA ๊ฒ€์‚ฌ์šฉ์œผ๋กœ๋‚จ๊ธฐ๊ณ ๋‚˜๋จธ์ง€๋Š”์ƒˆ๋กœ์šด์ฆ์‹๋ฐฐ์–‘์•ก์—์˜ฎ๊ฒจ๊ณ„์†๋ฐฐ์–‘ํ•œ๋‹ค. 5 ์•„๋ž˜์˜ IFA ๋ฐฉ๋ฒ•์œผ๋กœํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค๊ฐ์—ผ์—ฌ๋ถ€๋ฅผํ™•์ธํ•˜์—ฌ 100% ์˜์„ธํฌ๊ฐ€๊ฐ์—ผ๋˜์—ˆ์„๋•Œ๋ฐฐ์–‘์„์ค‘์ง€ํ•˜๊ณ ์ƒ์ธต์•ก์„๊ฑท์–ด์„œ -70 ์—๋ณด๊ด€ํ•˜๊ณ ์ดํ›„์‹คํ—˜์—์‚ฌ์šฉํ•œ๋‹ค. 6 ๊ณ„๋Œ€๋ฐฐ์–‘ํšŸ์ˆ˜๋Š”๋ณดํ†ต 5ํšŒ๊นŒ์ง€์ง„ํ–‰ํ•˜๋ฉฐ๊ทธ๋•Œ์—๋„ IFA์ƒ์œผ๋กœ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€๊ด€์ฐฐ ์ œ 10 ์žฅ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด 803

๋˜์ง€์•Š๊ณ  RT-PCR๋กœ์œ ์ „์ž๊ฐ€๊ฒ€์ถœ๋˜์ง€์•Š์„๋•Œ์—๋Š”๊ฒ€์ฒด์—๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€์กด์žฌํ•˜์ง€์•Š๋Š”๊ฒƒ์œผ๋กœํŒ์ •ํ•œ๋‹ค. 2) ๊ฐ„์ ‘๋ฉด์—ญํ˜•๊ด‘ํ•ญ์ฒด๋ฒ• (IFA) ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ๊ฐ์—ผ์‹œํ‚จ Vero E6 ์„ธํฌ๋ฅผ์Šฌ๋ผ์ด๋“œ์ƒ์—๊ณ ์ •์‹œํ‚ค๊ณ ๊ฒ€์ฒดํ˜ˆ์ฒญ๊ณผ๋ฐ˜์‘์‹œ์ผœ์„œํ˜ˆ์ฒญ๋‚ด์—์กด์žฌํ•˜๋Š”ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์—๋Œ€ํ•œํ•ญ์ฒด์œ ๋ฌด๋ฅผ์กฐ์‚ฌํ•˜๋Š”๋ฐฉ๋ฒ•์ด๋‹ค. ์ด๋•Œ๋ฐœ๊ฒฌ๋˜๋Š”ํ•ญ์ฒด๋Š”๊ทธ๋ฃนํŠน์ดํ•ญ์ฒด๋กœ์„œํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์—์†ํ•œ๋ชจ๋“ ํ˜ˆ์ฒญํ˜•์—๋ชจ๋‘๋ฐ˜์‘ํ•œ๋‹ค. ํ•ญ์ฒด๊ฐ€๊ฒ€์‚ฌ์—์˜ํ•ดํ˜„์ฆ์—ฌ๋ถ€๋ฅผ๊ฐ€๋ฆฌ๊ธฐ์œ„ํ•ด์„œ๋Š”๊ธ‰์„ฑ๊ธฐํ˜ˆ์ฒญ๊ณผํšŒ๋ณต๊ธฐํ˜ˆ์ฒญ์„๋™์‹œ์—๊ฒ€์‚ฌํ•˜์—ฌํ•ญ์ฒด๊ฐ€์˜์ฆ๊ฐ€๋ณ€ํ™”๋ฅผ๋ณด์•„์•ผ๋งŒํ•œ๋‹ค. (1) ํ•ญ์›์Šฌ๋ผ์ด๋“œ์ค€๋น„ 1 75 cm2์„ธํฌ๋ฐฐ์–‘ํ”Œ๋ผ์Šคํฌ์— 5% FBS๊ฐ€ํฌํ•จ๋œ EMEM (Eagle s modified essential medium) ๋ฐฐ์–‘์•ก์„์ด์šฉํ•˜์—ฌ Vero E6 ์„ธํฌ๋ฅผ๋‹จ์ธต๋ฐฐ์–‘ํ•œ๋‹ค (70~ 80%). 2 ๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ 1.0 MOI๋กœ์ ‘์ข…ํ•˜๊ณ  1~1.5์‹œ๊ฐ„ 37 ์—์„œํก์ฐฉ์‹œํ‚จ๋‹ค. 3 ๋ฐ”์ด๋Ÿฌ์Šค์šฉ์•ก์„์ œ๊ฑฐํ•˜๊ณ  10% FBS ํ•จ์œ  EMEM์„์ฒจ๊ฐ€ํ•˜์—ฌ์•ฝ 7์ผ๊ฐ„ 37, 5% CO 2 ๋ฐฐ์–‘๊ธฐ์—์„œ๋ฐฐ์–‘ํ•œ๋‹ค. 4 ๋ฐฐ์–‘ 7์ผ์งธ๋ฐฐ์–‘์•ก์„์ œ๊ฑฐํ•˜๊ณ ์ ์ •๋Ÿ‰์˜ PBS๋กœ์„ธ์ฒ™ํ•œ๋‹ค์Œ 0.25% ํŠธ๋ฆฝ์‹ ์œผ๋กœ์ฒ˜๋ฆฌํ•˜์—ฌ์„ธํฌ๋ฅผํ”Œ๋ผ์Šคํฌ๋กœ๋ถ€ํ„ฐ๋ถ„๋ฆฌ์‹œํ‚จ๋‹ค. 5 5% FBS ํ•จ์œ  EMEM์—๋ถ€์œ ํ•œํ›„๊ฐ™์€๋ฐฐ์–‘์•ก์œผ๋กœ 2ํšŒ์„ธ์ฒ™ํ•˜๊ณ ๋‹ค์‹œ PBS๋กœ 3ํšŒ์„ธ์ฒ™ํ•œ๋‹ค. 6 3~4 10 6 cells/ ml์ด๋˜๋„๋ก PBS๋ฅผ์ฒจ๊ฐ€ ( ์•ฝ 1~1.5 ml ) ํ•˜์—ฌ์„ธํฌ๋ฅผ๋ถ€์œ ์‹œํ‚จํ›„ํ…Œํ”Œ๋ก ์ฝ”ํŒ…์ฒ˜๋ฆฌ๋œ์Šฌ๋ผ์ด๋“œ์˜์›ฐ์—๋ถ€์œ ์•ก 5~25 μl ( ์›ฐ์˜ํฌ๊ธฐ์—๋”ฐ๋ผ๋‹ค๋ฆ„ ) ๋ฅผ๋–จ์–ด๋œจ๋ฆฐ๋‹ค. 7 ์ƒ์˜จ์—์„œ๊ฑด์กฐ์‹œํ‚จํ›„์‚ฌ์šฉ์ „๊นŒ์ง€ -70 ์—๋ณด๊ด€ํ•œ๋‹ค. (2) ๊ฐ„์ ‘๋ฉด์—ญํ˜•๊ด‘ํ•ญ์ฒด๋ฒ• 1-70 ์—๋ณด๊ด€์ค‘์ธํ•ญ์›์Šฌ๋ผ์ด๋“œ๋ฅผ๊ณต๊ธฐ์ค‘์—์„œ๊ฑด์กฐ์‹œํ‚จ๋‹ค. 2-20 ์—๋ณด๊ด€ํ–ˆ๋˜์•„์„ธํ†ค์—์Šฌ๋ผ์ด๋“œ๋ฅผ๋„ฃ์–ด 10๋ถ„๊ฐ„๊ณ ์ •์‹œํ‚จ๋‹ค. 3 ๊ฒ€์ฒดํ˜ˆ์ฒญ์„ 1:32๋ถ€ํ„ฐ 2๋ฐฐ๋‹จ๊ณ„ํฌ์„ํ•˜์—ฌํ•ญ์›์Šฌ๋ผ์ด๋“œ์— 25 μl์”ฉ๊ฐ์›ฐ์—๋–จ์–ด๋œจ๋ฆฌ๊ณ ํ•ญ์Šต์ƒ์ž์—๋„ฃ์–ด 37 ํ•ญ์˜จ๋ฐฐ์–‘๊ธฐ์—์„œ 30๋ถ„๊ฐ„๋ฐ˜์‘์‹œํ‚จ๋‹ค. 4 PBS๋กœ 5๋ถ„๊ฐ„ 3ํšŒ์„ธ์ฒ™ํ•œ๋‹ค. 804 ๊ฐ์—ผ๋ณ‘์‹คํ—˜์‹ค์ง„๋‹จ์ œ 4 ๋ถ€๋ฐ”์ด๋Ÿฌ์Šค์งˆํ™˜

5 FITC-conjugated anti-igg๋ฅผ 25 μl์”ฉ๊ฐ์›ฐ์—๋–จ์–ด๋œจ๋ฆฌ๊ณ ํ•ญ์Šต์ƒ์ž์—๋„ฃ์–ด 37 ์—์„œ 30๋ถ„๊ฐ„๋ฐ˜์‘์‹œํ‚จ๋‹ค. 6 PBS๋กœ 5๋ถ„๊ฐ„ 3ํšŒ์„ธ์ฒ™ํ•œํ›„์Šฌ๋ผ์ด๋“œ๋ฅผ๊ฑด์กฐ์‹œํ‚จ๋‹ค. 7 ๋งˆ์šดํŒ…์šฉ์•ก ( ๊ธ€๋ฆฌ์„ธ๋ฆฐ :PBS=9:1, ph 9.0, ์ƒํ’ˆํ™”๋œ๊ฒƒ๋„์žˆ์Œ ) ์„ํ•œ๋ฐฉ์šธ๋–จ์–ด๋œจ๋ฆฌ๊ณ ์ปค๋ฒ„๊ธ€๋ผ์Šค๋ฅผ์˜ฌ๋ คํ˜•๊ด‘ํ˜„๋ฏธ๊ฒฝ์œผ๋กœํŠน์ดํ˜•๊ด‘์„๊ด€์ฐฐํ•œ๋‹ค. 8 ์–‘์„ฑ๋Œ€์กฐ์™€์Œ์„ฑ๋Œ€์กฐํ˜ˆ์ฒญ์˜์ •์ƒ๋ฐ˜์‘์—ฌ๋ถ€๋ฅผ๋จผ์ €ํ™•์ธํ•œํ›„ํ˜•๊ด‘์„๊ด€์ฐฐํ• ์ˆ˜์žˆ๋Š”ํฌ์„๋ฐฐ์œจ๊ฐ’์„ํ•ญ์ฒด๊ฐ€๋กœํŒ๋…ํ•œ๋‹ค. 3) ์œ ์ „์ž๊ฒ€์ถœ๋ฒ• (multiplex RT-PCR) ์„ธํฌ๋ฐฐ์–‘๋ฒ•์€๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ์ง์ ‘๋ถ„๋ฆฌํ• ์ˆ˜์žˆ๋Š”์ •ํ™•ํ•œ๋ฐฉ๋ฒ•์ด์ง€๋งŒ์‹œ๊ฐ„์ด๋งŽ์ด์†Œ์š”๋˜๋Š”๋‹จ์ ์ด์žˆ๊ณ ๊ฐ„์ ‘๋ฉด์—ญํ•ญ์ฒด๋ฒ•๋“ฑ์˜ํ•ญ์ฒด๊ฒ€์‚ฌ๋ฒ•์€๊ธ‰์„ฑ๊ธฐ์™€ํšŒ๋ณต๊ธฐ๊ฒ€์ฒด๊ฐ€๋™์‹œ์—ํ•„์š”ํ•˜๋ฉฐ๋ฐ”์ด๋Ÿฌ์Šค์˜์กด์žฌ๋ฅผ์ง์ ‘์ฆ๋ช…ํ•˜๋Š”๋ฐฉ๋ฒ•์€์•„๋‹ˆ๋‹ค. ์ด์—๋ฐ˜ํ•ด์œ ์ „์ž๊ฒ€์ถœ๋ฒ•์€์‹ ์†ํ•˜๊ฒŒ๊ฒ€์ฒด๋‚ด์—์„œ๋ฐ”์ด๋Ÿฌ์Šค์กด์žฌ์œ ๋ฌด๋ฅผ์ง์ ‘์ ์œผ๋กœํŒ์ •ํ• ์ˆ˜์žˆ๋‹ค. ๋‹จ, ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ดํ™˜์ž์˜๊ฒฝ์šฐํ˜ˆ์ฒญ๋‚ด๋ฐ”์ด๋Ÿฌ์Šค์กด์žฌ๊ธฐ๊ฐ„ (viremia) ์ด์งง์•„๊ฒ€์ฒด์ฑ„์ทจ์‹œ๊ธฐ๊ฐ€๋งค์šฐ์ค‘์š”ํ•˜๋ฉฐ๋ฐฉ๋ฒ•์ด๋ฏผ๊ฐํ•˜๋ฏ€๋กœ์‹คํ—˜์‹ค๋‚ด๊ฒ€์ฒด๊ฐ„์˜ค์—ผ์œผ๋กœ์ธํ•œ์ž˜๋ชป๋œ๊ฒฐ๊ณผ๋ฅผ์–ป์„์ˆ˜์žˆ๋‹ค๋Š”๋‹จ์ ์ด์žˆ์œผ๋ฏ€๋กœ์ฃผ์˜ํ•ด์•ผํ•œ๋‹ค. 1 ๊ฒ€์ฒด๋กœ๋ถ€ํ„ฐ RNA๋ฅผ๋ฐ”์ด๋Ÿฌ์Šค RNA ์ถ”์ถœํ‚คํŠธ๋˜๋Š” Trizol (GibcoBRL) ์šฉ์•ก์„์‚ฌ์šฉํ•˜์—ฌ๋ถ„๋ฆฌํ•œ๋‹ค. 2 cdna ํ•ฉ์„ฑ๋ฐ˜์‘์€ 3 μl์˜ 5X RT buffer, 1 μl์˜ 10 mm dntps (datp, dgtp, dctp, dttp), 1 μl์˜ Hanta-S-F1 primer (10 pmol/ μl ), 1 μl์˜ 0.1 M DTT, 1 μl์˜ RNase inhibitor (40 units/ μl ), 1 μl์˜ Superscript RTase (200 units/ μl ), 10 μl์˜ RNA์— 3์ฐจ์ฆ๋ฅ˜์ˆ˜๋ฅผ์ฒจ๊ฐ€ํ•˜์—ฌ 30 μl๋ฐ˜์‘์•ก์„๋งŒ๋“ค๊ณ  42 ์—์„œ 1์‹œ๊ฐ„๋ฐ˜์‘์‹œํ‚จ๋‹ค ( ํ‘œ 3). 3 1์ฐจ PCR์€ 2.5 μl์˜ 10X PCR buffer, 1 μl์˜ 10 mm dntps (datp, dgtp, dctp, dttp), 1 μl์˜ Hanta-S-F1 primer (10 pmol/ μl ), 1 μl์˜ Hanta-S-R1 primer (10 pmol/ μl ), 0.5 μl์˜ Taq polymerase (5 U/ μl ), 5 μl์˜ cdna์— 3์ฐจ์ฆ๋ฅ˜์ˆ˜๋ฅผ์ฒจ๊ฐ€ํ•˜์—ฌ 25 μl๋ฐ˜์‘์•ก์„๋งŒ๋“ค๊ณ  94 ์—์„œ 5๋ถ„๋™์•ˆ๋ณ€์„ฑํ•œํ›„, 94 1๋ถ„, 55 1๋ถ„, 72 1๋ถ„๊ฐ„ 30ํšŒ๋ฐ˜๋ณตํ•œ๋‹ค์Œ 72 ์—์„œ 10๋ถ„๊ฐ„์—ฐ์žฅํ•˜์—ฌ 4 ์—์„œ์ •์น˜ํ•œ๋‹ค ( ํ‘œ 3). 4 2์ฐจ PCR์€ 2.5 μl์˜ 10X PCR buffer, 1 μl์˜ 10 mm dntps (datp, dgtp, ์ œ 10 ์žฅ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด 805

dctp, dttp), 0.5 μl์˜ Hanta-S-R2 primer (10 pmol/ μl ), 0.5 μl์˜ HTN-S- 756 primer (10 pmol/ μl ), 0.5 μl์˜ SEO-S-847 primer (10 pmol/ μl ), 0.5 μl์˜ PUU-S-945 primer (10 pmol/ μl ), 0.5μl์˜ Taq polymerase (5 U/ μl ), 5 μl์˜ 1์ฐจ PCR ์‚ฐ๋ฌผ์— 3์ฐจ์ฆ๋ฅ˜์ˆ˜๋ฅผ์ฒจ๊ฐ€ํ•˜์—ฌ 25 μl๋ฐ˜์‘์•ก์„๋งŒ๋“ค๊ณ  94 ์—์„œ 5๋ถ„๋™์•ˆ๋ณ€์„ฑํ•œํ›„, 94 30์ดˆ, 62 45์ดˆ, 72 30๋ถ„๊ฐ„ 35ํšŒ๋ฐ˜๋ณตํ•œ๋‹ค์Œ 72 ์—์„œ 10๋ถ„๊ฐ„์—ฐ์žฅํ•˜์—ฌ 4 ์—์„œ์ •์น˜ํ•œ๋‹ค. 5 ์ „๊ธฐ์˜๋™์œผ๋กœ์ฆํญ์‚ฐ๋ฌผ์„๊ด€์ฐฐํ•œ๋‹ค. 1์ฐจ PCR ์‚ฐ๋ฌผ์€๋ณดํ†ต์ „๊ธฐ์˜๋™์ƒ์—์„œํ™•์ธ๋˜์ง€์•Š์œผ๋ฉฐ, 2์ฐจ PCR์˜์ฆํญ๊ฒฐ๊ณผ๋ฌผ์€์ „๊ธฐ์˜๋™์ƒ์—์„œํ™•์ธํ• ์ˆ˜์žˆ๋‹ค. Mulltiplex PCR์˜๊ฒฝ์šฐ์ฆํญ๋ฐด๋“œ์˜๊ธธ์ด์—๋”ฐ๋ผ์„œํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์˜์ข…์„๊ตฌ๋ถ„ํ• ์ˆ˜์žˆ๋‹ค ( ๊ทธ๋ฆผ 3). ํ‘œ 3. ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค S ๋ถ„์ ˆ์œ ์ „์ž์—๋Œ€ํ•œ primer ์ข…๋ฅ˜ Primer PCR ์—ผ๊ธฐ์„œ์—ด (5 3 ) Hanta-S-F1 Hanta-S-R1 1 ์ฐจ ATTGAAGAACCTAGTGGACAGACAGC AGCTCTGGATCCATATCATC ์‚ฐ๋ฌผํฌ๊ธฐ (bp) 900 Hanta-S-R2 HTN-S-756 SEO-S-847 PUU-S-945 2 ์ฐจ AACACAATCATGGCATCTAAGAC AATTGAACCTTGCAAGCTTCTTCC AGACAAGGTGCACTTGCAGGAATG CAACATTGATTCGCCTAATGCACC 327 236 156 HTN SEO PUU : Primer M HTN SEO PUU HTN SEO PUU HTN SEO PUU : Virus 327 bp 236 bp 156 bp ๊ทธ๋ฆผ 3. Multiplex RT-PCR ์—์˜ํ•œํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์œ ์ „์ž๊ฒ€์ถœ M:1 kb plus size marker, HTN: ํ•œํƒ„๋ฐ”์ด๋Ÿฌ์Šค, SEO: ์„œ์šธ๋ฐ”์ด๋Ÿฌ์Šค, PUU: ํ‘ธ๋ง๋ผ๋ฐ”์ด๋Ÿฌ์Šค 806 ๊ฐ์—ผ๋ณ‘์‹คํ—˜์‹ค์ง„๋‹จ์ œ 4 ๋ถ€๋ฐ”์ด๋Ÿฌ์Šค์งˆํ™˜

4) IgM ํฌ์ฐฉํšจ์†Œ๋ฉด์—ญ์ธก์ •๋ฒ• IgM ํฌ์ฐฉํšจ์†Œ๋ฉด์—ญ๋ถ„์„๋ฒ•์€์šฐ๋ฆฌ๋‚˜๋ผ๋ฅผ๋น„๋กฏํ•ด์ค‘๊ตญ, ๋…์ผ๊ทธ๋ฆฌ๊ณ ์Šฌ๋กœ๋ฐ”๋‹ˆ์•„์—์„œ์ž„์ƒ๊ฒ€์ฒด๋ฅผ์ด์šฉํ•˜์—ฌ๊ฒ€์ฆํ•˜์˜€๋‹ค. ์ผ๋ฐ˜์ ์œผ๋กœํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์—๊ฐ์—ผํ™•์ธ๋œํ™˜์ž์˜ 95% ์ด์ƒ์ด๋ณ‘์›์—์ž…์›ํ•œ์ดํ›„๊ธ‰์„ฑ๊ธฐ๋ฐํšŒ๋ณต๊ธฐ๊ฒ€์ฒด์—์„œ๋ชจ๋‘๋†’์€ IgM ์ˆ˜์ค€์„๋ณด์ด๋Š”๊ฒƒ์œผ๋กœ์•Œ๋ ค์ ธ์žˆ๋‹ค. ๋”ฐ๋ผ์„œ์ด๋ฐฉ๋ฒ•์€ํ•œํƒ„๋ฐ”์ด๋Ÿฌ์Šค, ์„œ์šธ๋ฐ”์ด๋Ÿฌ์Šค๋ฐํ‘ธ๋ง๋ผ๋ฐ”์ด๋Ÿฌ์Šค๋“ฑ์—์„œ์ƒ๋‹นํžˆ๋ฏผ๊ฐ๋„๊ฐ€๋†’์€๋ฐฉ๋ฒ•์ด๋‹ค [5]. 1 96 ์›ฐํ”Œ๋ ˆ์ดํŠธ์— anti-human IgM์„์ฝ”ํŒ…์™„์ถฉ์•ก์— 1~2 μg / ml์œผ๋กœํฌ์„ํ•œ์•ก์„์›ฐ๋‹น 100 μl์”ฉ์ฒจ๊ฐ€ํ•œํ›„๋žฉ์œผ๋กœ์‹ธ์„œ 4 ์—์„œํ•˜๋ฃป๋ฐค์ •์น˜ํ•œ๋‹ค. 2 ํ•œ์›ฐ๋‹น 300 μl์„ธ์ฒ™์™„์ถฉ์•ก์œผ๋กœ์ตœ์†Œ 3๋ฒˆ์„ธ์ฒ™ํ•œ๋‹ค. 3 ํฌ์„์™„์ถฉ์•ก์—ํฌ์„ํ•œ๊ฒ€์ฒดํ˜ˆ์ฒญ๋ฐ๋Œ€์กฐ๊ตฐํ˜ˆ์ฒญ์„๊ฐ์›ฐ์—๋„ฃ๊ณ  37 ์—์„œ 1์‹œ๊ฐ„์ •์น˜ํ•œ๋‹ค. 4 ์„ธ์ฒ™์™„์ถฉ์•ก์œผ๋กœ 3๋ฒˆ์„ธ์ฒ™ํ•œํ›„๊ฐ์—ผ๋œ์„ธํฌ๋ฐฐ์–‘์ƒ์ธต์•ก ( ํ•ญ์› ) ์„๋ฏธ๋ฆฌ๊ฒฐ์ •ํ•œ์ ์ •ํฌ์„๋ฐฐ์ˆ˜ ( ๋ณดํ†ต 1:2~1:10) ๋กœ๋„ฃ์–ด์ค€๋‹ค. 5 ๋‹คํด๋ก  anti-hantavirus ํ•ญ์ฒด๋ฅผ์ ์ •ํฌ์„๋ฐฐ์ˆ˜ (1:500~1:10,000) ๋กœ์ฒจ๊ฐ€ํ•˜๊ณ  37 ์—์„œ 1์‹œ๊ฐ„์ •์น˜ํ•œ๋‹ค. 6 ์œ„์™€๊ฐ™์ด์„ธ์ฒ™ํ•˜๊ณ  HRPO ํ‘œ์ง€๋œ anti-rabbit IgG ํ•ญ์ฒด๋ฅผ 0.1 μg / ml๋กœ๊ฐ์›ฐ๋‹น 100 μl์”ฉ์ฒจ๊ฐ€ํ•œํ›„์— 37 ์—์„œ 1์‹œ๊ฐ„์ •์น˜ํ•œ๋‹ค. 7 ๋งˆ์ง€๋ง‰์œผ๋กœ์„ธ์ฒ™ํ•œํ›„๊ธฐ์งˆ์„์ฒจ๊ฐ€ํ•˜๊ณ  37 ์—์„œ์•ฝ 30๋ถ„๋™์•ˆ๋ฐ˜์‘์‹œ์ผœ๋ฐœ์ƒ‰์‹œํ‚จ๋‹ค. 8 ํšจ์†Œ๋ฉด์—ญ์ธก์ •๋ฒ•ํŒ๋…๊ธฐ๋ฅผ์ด์šฉํ•˜์—ฌ 414 nmํŒŒ์žฅ์—์„œ OD ๊ฐ’์„์ธก์ •ํ•œ๋‹ค. 5) ํ”Œ๋ผํฌ๊ฐ์†Œ์ค‘ํ™”ํ•ญ์ฒด์‹œํ—˜๋ฒ• (plaque reduction neutralization test) ๊ฒ€์ฒดํ˜ˆ์ฒญ๋‚ด์—์กด์žฌํ•˜๋Š”ํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์—๋Œ€ํ•œํ•ญ์ฒด๊ฐ€๋ฅผ์กฐ์‚ฌํ•˜๋Š”๋ฐฉ๋ฒ•์œผ๋กœ IFA์™€๊ฐ™์ง€๋งŒ์ค‘ํ™”ํ•ญ์ฒด๊ฐ€๋ฅผ์ธก์ •ํ• ์ˆ˜์žˆ์–ด์„œ๋ฐฑ์‹ ์˜ํšจ๋Šฅํ‰๊ฐ€๋“ฑ์—์ด์šฉ๋˜๋ฉฐ์ค‘ํ™”ํ•ญ์ฒด๋Š”์ผ๋ฐ˜์ ์œผ๋กœํ•œํƒ€๋ฐ”์ด๋Ÿฌ์Šค์ข…๋งˆ๋‹ค์ฐจ์ด๊ฐ€์žˆ์–ด๋ฐ”์ด๋Ÿฌ์Šค์ข…์„๊ตฌ๋ณ„ํ•˜๋Š”๋ฐ์ด์šฉํ• ์ˆ˜์žˆ๋‹ค. (1) ํ”Œ๋ผํฌ์‹œํ—˜๋ฒ• (plaque assay) 1 Vero E6 ์„ธํฌ์ฃผ๋ฅผ 6 ์›ฐํ”Œ๋ ˆ์ดํŠธ์—์„œ 3์ผ๊ฐ„๋ฐฐ์–‘ํ•œ๋‹ค (80~90%). 2 ๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ 10๋ฐฐ์”ฉ๋‹จ๊ณ„์ ์œผ๋กœ 10% FBS์™€ํ•ญ์ƒ์ œ๊ฐ€์ฒจ๊ฐ€๋œ EMEM์œผ๋กœํฌ์„ํ•œ๋‹ค. ์ œ 10 ์žฅ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด 807

3 ํฌ์„ํ•œ๋ฐ”์ด๋Ÿฌ์Šค์šฉ์•ก์„ 0.2~0.4 ml์ฒจ๊ฐ€ํ•˜์—ฌ 37 ์—์„œ 1~1.5 ์‹œ๊ฐ„๋ฐฐ์–‘ํ•œ๋‹ค. 4 PBS๋กœ์„ธ์ฒ™ํ•œํ›„์•„๊ฐ€๋กœ์ฆˆ๋ฐฐ์–‘์•ก์„๋ถ“๊ณ ์ƒ์˜จ์—์„œ๊ตณํžŒ๋‹ค์Œ 7์ผ๊ฐ„ ( ํ‘ธ๋ง๋ผ 10์ผ ) 37, 5% CO 2 ๋ฐฐ์–‘๊ธฐ์—์„œ๋ฐฐ์–‘ํ•œ๋‹ค ( ์•„๊ฐ€๋กœ์ฆˆ๋ฐฐ์–‘์•ก์กฐ์„ฑ์€ ๋ฐฐ์ง€๋ฐ์‹œ์•ฝ ๋ถ€๋ถ„์ฐธ์กฐ ). 5 ์œ„์˜์•„๊ฐ€๋กœ์ฆˆ๋ฐฐ์–‘์•ก์—์„œ FBS๋ฅผ 5% ๋กœ์ค„์ด๊ณ  neutral red ์šฉ์•ก (3.3 g/l) ์„ 5% ๋˜๊ฒŒ์ฒจ๊ฐ€ํ•œ์•„๊ฐ€๋กœ์ฆˆ๋ฐฐ์–‘์•ก์„๋ถ“๊ณ ์ƒ์˜จ์—์„œ๊ตณํžŒ๋‹ค์Œํ”Œ๋ผํฌ๊ฐ€ํ˜•์„ฑ๋ ๋•Œ๊นŒ์ง€ ( ๋ณดํ†ต 24์‹œ๊ฐ„ ) ๋ฐฐ์–‘ํ•œ๋‹ค. 6 ์—ญ๊ฐ€ (pfu/ ml ) ๋ฅผ๊ณ„์‚ฐํ•˜๊ธฐ์œ„ํ•œ์ ์ •ํ”Œ๋ผํฌ์ˆ˜๋Š” 10~100๊ฐœ์ด๋ฉฐ๋‹ค์Œ๊ณผ๊ฐ™์ด๊ณ„์‚ฐํ•œ๋‹ค. pfu/ ml = [ ํ”Œ๋ผํฌ์ˆซ์ž ํฌ์„๋ฐฐ์ˆ˜ (1/ ์ ‘์ข…๋Ÿ‰ )]/ ml (2) ์ค‘ํ™”ํ•ญ์ฒด๊ฐ€์ธก์ • 1 ๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ 2% FBS์™€ํ•ญ์ƒ์ œ๊ฐ€์ฒจ๊ฐ€๋œ EMEM์œผ๋กœ 500~1,000 pfu/ ml๋˜๊ฒŒํฌ์„ํ•œ๋‹ค. 2 ๊ฒ€์ฒดํ˜ˆ์ฒญ๊ณผ๋Œ€์กฐ๊ตฐํ˜ˆ์ฒญ์„ 2% FBS์™€ํ•ญ์ƒ์ œ๊ฐ€์ฒจ๊ฐ€๋œ EMEM์œผ๋กœ๊ฐ๊ฐ 1:10๋ถ€ํ„ฐ๋‹จ๊ณ„ํฌ์„ํ•˜๊ณ  56 ์—์„œ 30๋ถ„๊ฐ„๋ฐฐ์–‘ํ•˜์—ฌ๋ถˆํ™œ์„ฑํ™”์‹œํ‚จ๋‹ค. 3 ํฌ์„ํ•œ๋ฐ”์ด๋Ÿฌ์Šค์šฉ์•ก๊ณผ๋‹จ๊ณ„ํฌ์„ํ•œ๊ฒ€์ฒด๋ฅผ๊ฐ™์€๋ถ€ํ”ผ๋กœ์„ž์€ํ›„์— 35 ์—์„œ 1์‹œ๊ฐ„๋ฐฐ์–‘ํ•œํ›„ 4 ์—์„œํ•˜๋ฃป๋ฐค์ •์น˜ํ•œ๋‹ค. 4 ํ”Œ๋ผํฌ์‹œํ—˜๋ฒ•์„์œ„์™€๊ฐ™์ด์ˆ˜ํ–‰ํ•œ๋‹ค. 5 ์Œ์„ฑ๋Œ€์กฐ๊ตฐ๊ณผ๋น„๊ตํ•˜์—ฌํ”Œ๋ผํฌ์ˆซ์ž์˜๊ฐ์†Œ์ •๋„๋กœ์ค‘ํ™”ํ•ญ์ฒด๊ฐ€๋ฅผ๊ฒฐ์ •ํ•œ๋‹ค ( ๋ณดํ†ต์Œ์„ฑ๋Œ€์กฐ๊ตฐ์˜ 50% ํ”Œ๋ผํฌ๊ฐ€๋‚˜ํƒ€๋‚˜๋Š”ํฌ์„๋ฐฐ์ˆ˜๋ฅผํ•ญ์ฒด๊ฐ€๋กœ์ •ํ•œ๋‹ค ). 6) ํŒ์ •๊ธฐ์ค€์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์—ํ•ฉ๋‹นํ•œ์ž„์ƒ์ ํŠน์ง•์„๋‚˜ํƒ€๋‚ด๋ฉด์„œ, ๊ฒ€์ฒด ( ํ˜ˆ์•ก, ๋‡Œ์ฒ™์ˆ˜์•ก๋“ฑ ) ์—์„œ๋ฐ”์ด๋Ÿฌ์Šค๋˜๋Š”๋ฐ”์ด๋Ÿฌ์Šคํ•ญ์›์ด๋ถ„๋ฆฌ๋˜์—ˆ๊ฑฐ๋‚˜๊ธ‰์„ฑ๊ธฐํ˜ˆ์ฒญ์—์„œ IgM ํ•ญ์ฒด๊ฐ€๊ฒ€์ถœ๋œ๊ฒฝ์šฐ, ๊ทธ๋ฆฌ๊ณ ํšŒ๋ณต๊ธฐํ˜ˆ์ฒญ์˜ํ•ญ์ฒด๊ฐ€๊ฐ€๊ธ‰์„ฑ๊ธฐ์—๋น„ํ•˜์—ฌ 4๋ฐฐ์ด์ƒ์ฆ๊ฐ€ํ•˜์˜€์„๊ฒฝ์šฐํ™˜์ž๋กœํŒ์ •ํ•œ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜์ž„์ƒ์ ํŠน์ง•๋ฐ์—ญํ•™์ ์—ฐ๊ด€์„ฑ์„๊ฐ์•ˆํ•˜๋ฉด์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด์ด์˜์‹ฌ๋˜์ง€๋งŒ์‹คํ—˜์‹ค๊ฒ€์‚ฌ๋ฐฉ๋ฒ•์—์˜ํ•ดํ•ด๋‹น๋ณ‘์›์ฒด๊ฐ์—ผ์ดํ™•์ธ๋˜์ง€์•Š์•˜์„๊ฒฝ์šฐ์—๋Š”์˜์‚ฌํ™˜์ž๋กœํŒ์ •ํ•œ๋‹ค [1]. 808 ๊ฐ์—ผ๋ณ‘์‹คํ—˜์‹ค์ง„๋‹จ์ œ 4 ๋ถ€๋ฐ”์ด๋Ÿฌ์Šค์งˆํ™˜

์ฐธ๊ณ ๋ฌธํ—Œ 1) ๊ตญ๋ฆฝ๋ณด๊ฑด์›. ์ „์—ผ๋ณ‘๋ณด๊ณ ๋ฐ์ •๋ณด๊ด€๋ฆฌ์ง€์นจ. p134-135. 2002. 2) ์งˆ๋ณ‘๊ด€๋ฆฌ๋ณธ๋ถ€๊ตญ๋ฆฝ๋ณด๊ฑด์—ฐ๊ตฌ์›. ๊ฐ์—ผ๋ณ‘์‹คํ—˜์‹ค์ง„๋‹จ์ผ๋ฐ˜์‹œํ—˜๋ฒ•. p138-141, 2003. 3) ์งˆ๋ณ‘๊ด€๋ฆฌ๋ณธ๋ถ€์ „์—ผ๋ณ‘์ •๋ณด๋ง : ์ „์—ผ๋ณ‘๋ณ„์ •๋ณด http://dis.cdc.go.kr/information. 4) ์งˆ๋ณ‘๊ด€๋ฆฌ๋ณธ๋ถ€. 2003 ์ „์—ผ๋ณ‘ํ†ต๊ณ„์—ฐ๋ณด. 2004. 5) Alexeyev OA, Elgh F, Ahlm C, Stigbrand T, Settergren B, Wadell G, Juto P. Hantavirus antigen detection using human serum immunoglobulin M as the capturing antibody in an enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1996, 54(4):367-371. 6) Berkelman RL. Emerging infectious disease in the United States, 1993 (Review) J Inf Dis 1994, 170(2):272-277. 7) Cho HW, Howard CR, Lee HW. Review of an inactivated vaccine against hantaviruses. Intervirology 2002, 45:328-333. 8) Lee HW, Calisher C, Schmaljohn C. Manual of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. WHO. 1999. 9) Lee HW, Lee PW, and Johnson KM. Isolation of the etiologic agent of Korean hemorrhagic fever. J Inf Dis 1978, 137:298-308. 10) Lee J. Hemorrhagic fever with reanl syndrome. J Kor Med Assoc 1994, 37: 1415-1426. 11) Nichol ST. Fields Virology (CD). Chapter 49. Bunyaviruses. 4th ed. Lippincott- Raven Publishers. 2001. 12) WHO. Haemorrhagic fever with renal syndrome:memorandum from a WHO meeting. Bull. WHO. 1983, 61:269-275. ์ œ 10 ์žฅ์‹ ์ฆํ›„๊ตฐ์ถœํ˜ˆ์—ด 809